Processing 00000000.tx.1: Amyloid Peptides Do Not Form Peptide-derived Free Radicals Spontaneously, but Can Enhance Metal-catalyzed Oxidation of Hydroxylamines to Nitroxides* Sergey I. 

Phrase: "Amyloid Peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Do"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "Peptide-derived Free Radicals Spontaneously,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   804   C0302912:radicals [Chemical Viewed Structurally]
   804   C0332296:free [Functional Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   771 E C0439807:Radical [Qualitative Concept]

Phrase: "but"

Phrase: "Can"

Phrase: "Enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "Metal-catalyzed Oxidation of Hydroxylamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025552:Metal [Inorganic Chemical]
   760   C0030011:Oxidation [Molecular Function]

Phrase: "to Nitroxides"

Phrase: "* Sergey I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Dikalov, Michael P. 

Phrase: "Dikalov,"

Phrase: "Michael P."
Processing 00000000.tx.3: Vitek, Kirk R. 

Phrase: "Vitek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553145:Vitek [Laboratory Procedure]

Phrase: "Kirk R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: Maples, and Ronald P. 

Phrase: "Maples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330996:Maples [Plant]
  1000   C1135778:Maples [Plant]

Phrase: "and"

Phrase: "Ronald P."
Processing 00000000.tx.5: Mason From the Laboratory of Pharmacology and Chemistry, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709,the Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710,and Centaur Pharmaceuticals, Inc., Sunnyvale, California 94086  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Amyloid (A) peptides play an important role in the pathogenesis of Alzheimer's disease. 

Phrase: "Mason From the Laboratory of Pharmacology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0331857:Mason [Health Care Related Organization]

Phrase: "and"

Phrase: "Chemistry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007996:Chemistry [Occupation or Discipline]
  1000   C0079107:chemistry [Classification]
  1000   C0201682:Chemistry [Laboratory Procedure]

Phrase: "NIEHS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1955979:NIEHS [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Research Triangle Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "North Carolina 27709,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0028407:North Carolina [Geographic Area]
   827   C1709269:North [Spatial Concept]

Phrase: "the Division of Neurology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0228059:division nervous system [Body System]
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Duke University Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   812   C1446468:Duke [Laboratory Procedure]

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "North Carolina 27710,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0028407:North Carolina [Geographic Area]
   827   C1709269:North [Spatial Concept]

Phrase: "and"

Phrase: "Centaur Pharmaceuticals,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   861   C1254351:Pharmaceuticals [Pharmacologic Substance]
   827 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Sunnyvale,"

Phrase: "California 94086  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amyloid (A) peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.6: Free radical generation by A peptides was suggested to be a key mechanism of their neurotoxicity. 

Phrase: "Free radical generation by A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a key mechanism of their neurotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.7: Reports that neurotoxic free radicals derived from A-(1-40) and A-(25-35) peptides react with the spin trap N-tert-butyl--phenylnitrone (PBN) to form a PBN/A peptide radical adduct with a specific triplet ESR signal assert that the peptide itself was the source of free radicals. 

Phrase: "Reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that neurotoxic free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0302912:radicals [Chemical Viewed Structurally]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0439807:Radical [Qualitative Concept]

Phrase: "derived from A-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "react with the spin trap N-tert-butyl"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0184047:trap [Medical Device]
   744   C0297331:TR-AP [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1336677:TR-AP [Gene or Genome]
   744   C1367342:TERT [Gene or Genome]
   744   C1415347:SPIN [Gene or Genome]
   744   C1705316:TERT [Gene or Genome]
   744   C1710330:TR-AP [Gene or Genome]
   744   C1823107:SPIN [Gene or Genome]

Phrase: "--"

Phrase: "phenylnitrone"

Phrase: "(PBN) to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a PBN/A peptide radical adduct with a specific triplet ESR signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "assert"

Phrase: "that"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "itself"

Phrase: "was"

Phrase: "the source of free radicals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]
Processing 00000000.tx.8: We now report that three A peptides, A-(1-40), A-(25-35), and A-(40-1), do not yield radical adducts with PBN from the Oklahoma Medical Research Foundation (OMRF). 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that three A peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "yield"

Phrase: "radical adducts with PBN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "from the Oklahoma Medical Research Foundation (OMRF)."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.9: In contrast to OMRF PBN, incubation of Sigma PBN in phosphate buffer without A peptides produced a three-line ESR spectrum. 

Phrase: "In contrast to OMRF PBN,"

Phrase: "incubation of Sigma PBN"

Phrase: "in phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "without A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced"

Phrase: "a three-line ESR spectrum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1883073:Spectrum [Quantitative Concept]
   812   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.10: It was shown that this nitroxide is di-tert-butylnitroxide and is formed in the Sigma PBN solution as a result of transition metal-catalyzed auto-oxidation of the respective hydroxylamine present as an impurity in the Sigma PBN. 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this nitroxide"

Phrase: "is"

Phrase: "di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "and"

Phrase: "is"

Phrase: "formed in the Sigma PBN solution"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0037633:Solution [Substance]
   753   C0205431:Formed [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1719918:Sigma [Intellectual Product]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of transition metal-catalyzed auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   804   C0030011:Oxidation [Molecular Function]
   804   C1441488:Auto [Laboratory Procedure]

Phrase: "of the respective hydroxylamine present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]

Phrase: "as an impurity"

Phrase: "in the Sigma PBN."
Processing 00000000.tx.11: Under some conditions, incubation of PBN from Sigma with A-(1-40) or A-(25-35) can stimulate the formation of di-tert-butylnitroxide. 

Phrase: "Under some conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "incubation of PBN"

Phrase: "from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "can"

Phrase: "stimulate"

Phrase: "the formation of di-tert-butylnitroxide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.12: It was shown that A peptides enhanced oxidation of cyclic hydroxylamine 1-hydroxy-4-oxo-2,2,6,6-tetramethylpiperidine (TEMPONE-H), which was strongly inhibited by the treatment of phosphate buffer with Chelex-100. 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "oxidation of cyclic hydroxylamine 1-hydroxy-4-oxo-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030011:Oxidation [Molecular Function]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "6-tetramethylpiperidine (TEMPONE-H),"

Phrase: "which"

Phrase: "was"

Phrase: "strongly"

Phrase: "inhibited by the treatment of phosphate buffer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with Chelex-100."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.13: It was shown that ferric and cupric ions are effective oxidants of TEMPONE-H. 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ferric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346593:Ferric [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "cupric ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "are"

Phrase: "effective oxidants of TEMPONE-H."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085403:Oxidants [Chemical Viewed Functionally]
Processing 00000000.tx.14: The data obtained allow us to conclude that under some conditions toxic A peptides A-(1-40) and A-(25-35) enhance metal-catalyzed oxidation of hydroxylamine derivatives, but do not spontaneously form peptide-derived free radicals.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that under some"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "toxic A peptides A-"

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "metal-catalyzed oxidation of hydroxylamine derivatives,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025552:Metal [Inorganic Chemical]
   753   C0030011:Oxidation [Molecular Function]

Phrase: "but"

Phrase: "do"

Phrase: "not spontaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "peptide-derived free radicals."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   812   C0302912:radicals [Chemical Viewed Structurally]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0439807:Radical [Qualitative Concept]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES As the leading cause of dementia, Alzheimer's disease (AD)1 is characterized by a loss of memory and neurons. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES As the leading cause of dementia,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0015127:cause [Functional Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1514811:Reference [Idea or Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]
   748   C1706462:Reference [Conceptual Entity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "characterized by a loss of memory"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0002622:Loss of memory [Mental or Behavioral Dysfunction]
           Memory loss
   833   C0751295:LOSS OF MEMORY [Sign or Symptom]
           Memory Loss
   753   C0025260:Memory [Mental Process]
   753   C0700327:memory [Finding]
   753   C1517945:Loss [Quantitative Concept]
   753   C1706377:Memory [Manufactured Object]
   753   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.16: These characteristics have been associated with brain lesions known as neurofibrillary tangles composed of Tau protein and amyloid plaques, which consist of amyloid (A) peptide. 

Phrase: "These characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristics [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "associated with brain lesions"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0221505:brain lesions [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0221198:lesions [Finding]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1546698:Lesion [Intellectual Product]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "known as neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]
   770   C0205309:Known [Qualitative Concept]

Phrase: "composed of Tau protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   819 E C1421563:protein tau [Gene or Genome]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "amyloid plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "which"

Phrase: "consist of amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0332529:CONSIST [Qualitative Concept]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) peptide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.17: In a small number of families, mutations in the genes for the amyloid peptide precursor (APP, chromosome 21) to A peptide for presenilin-1 (PSEN-1, chromosome 14), presenilin-2 (PSEN-2, chromosome 1) and for an anonymous gene on chromosome 12have been associated with AD. 

Phrase: "In a small number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "mutations in the genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for the amyloid peptide precursor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008664:Chromosome 21 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "to A peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PSEN-1,"

Phrase: "chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008656:Chromosome 14 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "presenilin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PSEN-2,"

Phrase: "chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "and for an anonymous gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017337:Gene [Gene or Genome]
   760   C1515981:And [Idea or Concept]
   760   C2346787:Anonymous [Qualitative Concept]
   760   C3245483:Anonymous [Intellectual Product]

Phrase: "on chromosome 12have"

Phrase: "been"

Phrase: "associated with AD."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.18: In contrast, Saunders and colleagues (1) discovered that a significant percentage of patients inheriting one or more of the epsilon-4 alleles of apolipoprotein-E (APOE4, chromosome 19) were at risk of acquiring AD at an earlier age than their counterparts expressing the more common epsilon-3 allele of APOE. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Saunders"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "discovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880355:Discover [Activity]

Phrase: "that"

Phrase: "a significant percentage of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "inheriting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:inheriting [Functional Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more of the epsilon-4 alleles of apolipoprotein-E"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   796   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   784   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   764   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002085:Alleles [Gene or Genome]
   742   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205172:More [Functional Concept]
   742   C0439098:Epsilon [Intellectual Product]

Phrase: "(APOE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "chromosome 19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008661:Chromosome 19 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "were at risk of acquiring AD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0035647:Risk [Qualitative Concept]
   753   C0439661:acquiring [Temporal Concept]
   719 E C1706701:Acquire [Activity]

Phrase: "at an earlier age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "than their counterparts"

Phrase: "expressing"

Phrase: "the more common epsilon-3 allele of APOE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.19: The observation that AD patients with mutant genes for APP, PSEN-1, or PSEN-2 have higher levels of A peptide than non-diseased controls (2, 3) argues that A peptide may cause AD. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that AD patients with mutant genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "for APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "PSEN-1,"

Phrase: "or"

Phrase: "PSEN-2"

Phrase: "have"

Phrase: "higher levels of A peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "than non-diseased controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "argues"

Phrase: "that A peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "AD."
Processing 00000000.tx.20: Further supporting this idea is the observation that APOE4 patients with AD display more amyloid plaques than those with APOE3 (4). 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "this idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "is"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that APOE4 patients with AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "more amyloid plaques than those"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "with APOE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.21: Based on neuropathological, genetic, and biochemical associations, the presence of amyloid peptide is a key component of AD. 

Phrase: "Based on neuropathological, genetic,"
Meta Candidates (Total=14; Excluded=10; Pruned=0; Remaining=4)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "biochemical associations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "the presence of amyloid peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a key component of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.22: A crucial link between A peptide and AD was provided by Yankner and colleagues (5), who showed that fibrillar aggregates of A peptide were toxic to neurons. 

Phrase: "A crucial link between A peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "AD"

Phrase: "was"

Phrase: "provided by Yankner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that fibrillar aggregates of A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "toxic to neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600688:toxic [Injury or Poisoning]
   790   C1407029:Toxic [Qualitative Concept]
Processing 00000000.tx.23: This seminal observation inspired a global quest to define the mechanism by which fibrillar A peptide mediated neurotoxicity. 

Phrase: "This seminal observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "inspired"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004048:Inspired [Organism Function]

Phrase: "a global quest to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750565:QUEST [Idea or Concept]

Phrase: "define"

Phrase: "the mechanism by which fibrillar A peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.24: One of the mechanisms proposed suggests that neurons exposed to A peptide suffer severe oxidative stress that may lead to their death. 

Phrase: "One of the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exposed to A peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "severe oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "that"

Phrase: "may"

Phrase: "lead to their death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0011065:Death [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1306577:Death, NOS [Finding]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.25: Clear evidence of oxidative stress in Alzheimer's disease has been provided by Smith et al. 

Phrase: "Clear evidence of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "provided by Smith et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0554249:Smith [Professional or Occupational Group]
   760   C1999230:Provided [Activity]
Processing 00000000.tx.26: (6), who found that neurons of AD patients contained nitrotyrosine modifications of proteins, which were not detected in age-matched control brains. 

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that neurons of AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "nitrotyrosine modifications of proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   786   C0033666:Protein Modification [Molecular Function]
   786   C2263112:protein modification [Molecular Function]
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "which"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in age-matched control brains."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   783   C0596948:brains control [Mental Process]
   753   C0001779:Age [Organism Attribute]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0150103:matched [Research Activity]
   753   C0243148:control [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1550141:Control [Substance]
   753   C1708943:Matched [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.27: Increased levels of lipid peroxides (7), reactive aldehydes such as hydroxynonenal (8), and oxidized DNA (9) have also been reported in AD brains, providing additional evidence of an oxidative stress component in the disease. 

Phrase: "Increased levels of lipid peroxides"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0428460:levels lipid [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "reactive aldehydes such as hydroxynonenal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001992:Aldehydes [Organic Chemical]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "oxidized DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(9"

Phrase: ")"

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported in AD brains,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C3273238:Report [Intellectual Product]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "additional evidence of an oxidative stress component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.28: The exact nature of the radical species generated in Alzheimer's diseased brains is unknown. 

Phrase: "The exact nature of the radical species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "generated in Alzheimer's diseased brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C3146294:Generated [Activity]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.29: In one line of investigation, Behl et al. 

Phrase: "In one line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "of investigation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "Behl et al."
Processing 00000000.tx.30: (10) demonstrated that cells exposed to fibrillar A peptide responded by releasing hydrogen peroxide and dying, a process that could be inhibited by the application of catalase to degrade the released peroxide. 

Phrase: "(10"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to fibrillar A peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "responded by releasing hydrogen peroxide"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020275:Hydrogen [Element, Ion, or Isotope]
   760   C0031180:Peroxide [Inorganic Chemical]
   760   C0523702:HYDROGEN [Laboratory Procedure]
   760   C0885426:hydrogen [Inorganic Chemical]
   760   C1283071:Releasing [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0391871:Release [Functional Concept]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "dying,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0184532:dying [Organism Function]
   928 E C0011065:Expired [Organism Function]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C1546956:Died [Finding]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "inhibited by the application of catalase to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0185125:Application [Health Care Activity]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1413138:CATALASE [Gene or Genome]
   748   C1947919:Application [Intellectual Product]
   748   C2347934:Application [Intellectual Product]
   748   C3539080:APPLICATION [Quantitative Concept]

Phrase: "degrade"

Phrase: "the released peroxide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031180:Peroxide [Inorganic Chemical]
Processing 00000000.tx.31: Subsequent reports have demonstrated cellular release of superoxide (11) and nitric oxide (12) in response to A peptide treatment. 

Phrase: "Subsequent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "demonstrated cellular release of superoxide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C1158882:superoxide release [Molecular Function]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(12"

Phrase: ")"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to A peptide treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.32: The effect of these radicals may be potentiated since A peptides also appear to inhibit the cellular redox mechanisms that normally protect cells from oxidative stress (13). 

Phrase: "The effect of these radicals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "potentiated"

Phrase: "since"

Phrase: "A peptides also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the cellular redox mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "that normally"

Phrase: "protect"

Phrase: "cells from oxidative stress"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.33: In a provocative hypothesis, Hensley et al. 

Phrase: "In a provocative hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "Hensley et al."
Processing 00000000.tx.34: (14) suggest that the A peptide itself spontaneously generates free radicals that can damage cells. 

Phrase: "(14"

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the A peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself spontaneously"

Phrase: "generates"

Phrase: "free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.35: By mixing the spin trap N-tert-butyl--phenylnitrone (PBN) with neurotoxic forms of the A peptide such as A-(1-40) and A-(25-35), they report the generation of ESR-detectable radical adducts in cell-free solutions (14-17). 

Phrase: "By mixing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205430:mixing [Functional Concept]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "the spin trap N-tert-butyl"

Phrase: "--"

Phrase: "phenylnitrone"

Phrase: "(PBN) with neurotoxic forms of the A peptide"

Phrase: "such as A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "they"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the generation of ESR-detectable radical adducts in cell-free solutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079411:Generation [Temporal Concept]
   738   C3146294:Generation [Activity]

Phrase: "(14-17"

Phrase: ")."
Processing 00000000.tx.36: They suggest that these radicals are generated by methionine oxidation (14, 15) or by the fragmentation of A peptide into smaller oligopeptide radicals (14, 15) that act as "shrapnel" to damage and eventually kill cells. 

Phrase: "They"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these radicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0302912:radicals [Chemical Viewed Structurally]
   966 E C0439807:Radical [Qualitative Concept]

Phrase: "are"

Phrase: "generated by methionine oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0030011:Oxidation [Molecular Function]
   770   C3146294:Generated [Activity]

Phrase: "(14,"

Phrase: "15"

Phrase: ")"

Phrase: "or by the fragmentation of A peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332472:Fragmentation [Anatomical Abnormality]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "into smaller oligopeptide radicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0302912:radicals [Chemical Viewed Structurally]
   793 E C0439807:Radical [Qualitative Concept]

Phrase: "(14,"

Phrase: "15"

Phrase: ")"

Phrase: "that"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "as ""shrapnel"" to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0522670:Shrapnel [Manufactured Object]

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "eventually"

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.37: Recently, these results were described as possibly artifactual due to contaminants in some of the preparations (18). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "described as possibly artifactual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2362652:Possibly [Qualitative Concept]

Phrase: "due to contaminants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827365:Contaminant [Substance]

Phrase: "in some"

Phrase: "of the preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.38: We have reinvestigated the spin-trapping studies of spontaneous free radical formation by A peptides. 

Phrase: "We"

Phrase: "have"

Phrase: "reinvestigated"

Phrase: "the spin-trapping studies of spontaneous free radical formation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "by A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.39: In contrast to previous literature (14-17), we now report that neurotoxic A-(1-40) and A-(25-35) in the presence of the spin trap PBN do not form ESR-detectable radical adducts spontaneously. 

Phrase: "In contrast to previous literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023866:Literature [Intellectual Product]
   861   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "(14-17"

Phrase: ")"

Phrase: ","

Phrase: "we now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that neurotoxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the spin trap PBN"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "ESR-detectable radical adducts spontaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596040:adducts [Chemical Viewed Structurally]
Processing 00000000.tx.40: Amyloid/PBN radical adducts (14-17) reported earlier were found to be di-tert-butylnitroxide and tert-butylhydronitroxide, which are formed by oxidation of the corresponding hydroxylamines. 

Phrase: "Amyloid/PBN radical adducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "(14-17"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "and"

Phrase: "tert-butylhydronitroxide,"

Phrase: "which"

Phrase: "are"

Phrase: "formed by oxidation of the corresponding hydroxylamines."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   748   C0020363:Hydroxylamines [Organic Chemical]
   748   C0030011:Oxidation [Molecular Function]
   748   C0205431:Formed [Functional Concept]
   714 E C0020362:Hydroxylamine [Inorganic Chemical]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714 E C1522492:Form [Functional Concept]
Processing 00000000.tx.41: We have investigated the possibility that toxic A may potentiate metal-catalyzed oxidation of hydroxylamine derivatives. 

Phrase: "We"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possibility"

Phrase: "that toxic A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "potentiate"

Phrase: "metal-catalyzed oxidation of hydroxylamine derivatives."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025552:Metal [Inorganic Chemical]
   753   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.42: Transition metals like iron and copper frequently contribute to reactions where molecules are oxidized, but the transition metal oxidation of hydroxylamine derivatives has not been previously studied. 

Phrase: "Transition metals like iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0682906:transition metal [Element, Ion, or Isotope]
   770   C0025552:Metals [Inorganic Chemical]
   770   C0599156:Transition [Cell or Molecular Dysfunction]
   770   C2700061:Transition [Activity]

Phrase: "and"

Phrase: "copper frequently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C2347872:Copper+ [Element, Ion, or Isotope]
   861   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "contribute to reactions where molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0567416:molecules [Substance]
   760   C1880177:Contribute [Activity]
   726   C0443286:Reaction [Functional Concept]
   726   C1114821:Reaction [Clinical Attribute]

Phrase: "are"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: ","

Phrase: "but"

Phrase: "the transition metal oxidation of hydroxylamine derivatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.43: A body of emerging work demonstrates that copper and iron are significantly associated with amyloid plaques in the brains of patients with AD, but not with the neuropil lacking plaques nor with control neuropil from healthy brains (19). 

Phrase: "A body of emerging work"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   765   C3533118:Amyloid bodies [Finding]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "demonstrates"

Phrase: "that copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with amyloid plaques"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   833   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with AD,"

Phrase: "but"

Phrase: "not with the neuropil lacking plaques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0228081:Neuropil [Cell Component]
   753   C0332268:Lacking [Qualitative Concept]
   753   C0333463:plaques [Acquired Abnormality]
   753   C1518422:Not [Functional Concept]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "nor with control neuropil"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C0228081:Neuropil [Cell Component]
   770   C0243148:control [Qualitative Concept]
   770   C1513854:NOR [Mammal]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "from healthy brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.44: Since A is retained on metal chelate columns charged with copper (20), and copper dramatically increases the rate of A aggregation into amyloid fibrils (21), then complexes of A and copper may contribute to the pathological oxidative stress associated with AD. 

Phrase: "Since"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "retained on metal chelate columns"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025552:Metal [Inorganic Chemical]
   760   C0333118:Retained [Functional Concept]
   726   C1185738:Column [Body Part, Organ, or Organ Component]
   726   C1706132:Column [Idea or Concept]

Phrase: "charged with copper"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1706211:Charged [Organism Attribute]
   790   C2347872:Copper+ [Element, Ion, or Isotope]
   790   C2348263:Copper [Element, Ion, or Isotope]
   756 E C0007961:Charge [Quantitative Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "copper dramatically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C2347872:Copper+ [Element, Ion, or Isotope]
   861   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of A aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "into amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "then complexes of A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "may"

Phrase: "contribute to the pathological oxidative stress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0030664:Pathological [Biomedical Occupation or Discipline]
   753   C0038435:Stress [Finding]
   753   C0311404:Oxidative [Functional Concept]
   753   C1521733:Pathological [Functional Concept]
   753   C1880177:Contribute [Activity]

Phrase: "associated with AD."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.45: We now report the effects of neurotoxic A-(1-40) and A-(25-35) and non-toxic A-(40-1) on the oxidation of hydroxylamine derivatives in the presence and absence of metals. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the effects of neurotoxic A-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0235032:Neurotoxic effect [Injury or Poisoning]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "and"

Phrase: "non-toxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "on the oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of hydroxylamine derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of metals."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.46: The data obtained allows us to conclude that the previously reported formation of amyloid/PBN radical adducts (14-17) in the Sigma PBN treated with A peptides can be explained as A peptide-stimulated, metal-catalyzed oxidation of the corresponding hydroxylamine impurities in Sigma PBN.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the previously reported formation of amyloid/PBN radical adducts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "(14-17"

Phrase: ")"

Phrase: "in the Sigma PBN"

Phrase: "treated with A peptides"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "explained as A peptide-stimulated, metal-catalyzed oxidation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0025552:Metal [Inorganic Chemical]
   744   C0030011:Oxidation [Molecular Function]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "of the corresponding hydroxylamine impurities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2698670:IMPURITIES [Regulation or Law]

Phrase: "in Sigma PBN."
Processing 00000000.tx.47: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Reagents-- PBN was obtained from the Oklahoma Medical Research Foundation (OMRF) Spin Trap Source (Oklahoma City, OK). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "--"

Phrase: "PBN"

Phrase: "was"

Phrase: "obtained from the Oklahoma Medical Research Foundation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0079816:Medical Research [Research Activity]
   778   C1556038:Medical Research [Professional or Occupational Group]
   748   C0016617:Foundation [Organization]
   748   C0028914:Oklahoma [Geographic Area]
   748   C0035168:research [Research Activity]
   748   C0205476:Medical [Functional Concept]
   748   C0242481:Research [Research Activity]
   748   C1301820:Obtained [Functional Concept]
   737   C2986512:Research Base [Organization]
   714 E C1706701:Obtain [Activity]

Phrase: "(OMRF"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: ")"

Phrase: "Spin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415347:SPIN [Gene or Genome]
  1000   C1823107:SPIN [Gene or Genome]

Phrase: "Trap Source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449416:Source [Finding]
   861   C1705919:Source [Idea or Concept]

Phrase: "(Oklahoma City,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0008848:City [Geographic Area]
   861   C0028914:Oklahoma [Geographic Area]
   861   C3262831:City [Clinical Attribute]

Phrase: "OK"

Phrase: ")."
Processing 00000000.tx.48: Two different lots (101H3696 and 87H36602) of PBN from Sigma were used. 

Phrase: "Two different lots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1115660:LOT [Intellectual Product]
   793   C1518000:Lot [Qualitative Concept]
   793   C1710198:Lot [Idea or Concept]

Phrase: "(101H3696"

Phrase: "and"

Phrase: "87H36602"

Phrase: ")"

Phrase: "of PBN"

Phrase: "from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.49: Deferoxamine (Desferal) was purchased from Sigma. 

Phrase: "Deferoxamine (Desferal)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.50: Di-tert-butylnitroxide (Aldrich), N-tert-butylhydroxylamine (TCI America, Portland, OR) and analytical grade Chelex-100 (Bio-Rad) were used. 

Phrase: "Di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "(Aldrich"

Phrase: ")"

Phrase: ","

Phrase: "N-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649604:N-tert-butylhydroxylamine [Organic Chemical]

Phrase: "(TCI America,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0002454:America [Geographic Area]
   789 E C0596070:American [Population Group]

Phrase: "Portland,"

Phrase: "OR)"

Phrase: "and"

Phrase: "analytical grade Chelex-100"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   812   C0441800:Grade [Classification]
   812   C0919553:Grade [Classification]
   812   C0936012:Analytical [Research Activity]
   812   C3244287:grade [Finding]

Phrase: "(Bio-Rad)"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.51: Synthetic A-(1-40), A-(25-35) and A-(40-1) peptides were purchased from Bachem (Torrance, CA). 

Phrase: "Synthetic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "purchased from Bachem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Torrance,"

Phrase: "CA)."
Processing 00000000.tx.52: These lots of A-(1-40) and A-(25-35), but not the A-(40-1) peptides, have been previously shown to kill neurons in a cell culture system (data not shown). 

Phrase: "These lots of A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1115660:LOT [Intellectual Product]
   737   C1518000:Lot [Qualitative Concept]
   737   C1710198:Lot [Idea or Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "neurons in a cell culture system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: TEMPONE-H was obtained from Alexis Corporation (Lufelfingen, Switzerland) (22). 

Phrase: "TEMPONE-H"

Phrase: "was"

Phrase: "obtained from Alexis Corporation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0445425:alexis [Intellectual Product]
   770   C0683758:Corporation [Organization]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(Lufelfingen,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.54: All other reagents were analytical grade. 

Phrase: "All"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "analytical grade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441800:Grade [Classification]
   861   C0919553:Grade [Classification]
   861   C3244287:grade [Finding]
Processing 00000000.tx.55: Preparation of PBN Stock Solution-- Stock solutions of PBN (150mM) in HPLC grade water were used to prepare final 50mM PBN solutions. 

Phrase: "Preparation of PBN Stock Solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "Stock solutions of PBN (150mM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0037633:Solutions [Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: ")"

Phrase: "in HPLC grade water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "final 50mM PBN solutions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0037633:Solutions [Substance]
   779 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.56: Preparation of TEMPONE-H Stock Solutions-- TEMPONE-H was dissolved in oxygen-free HPLC grade water (30-min argon bubbled water) with 1mM Desferal. 

Phrase: "Preparation of TEMPONE-H Stock Solutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "TEMPONE-H"

Phrase: "was"

Phrase: "dissolved in oxygen-free HPLC grade water"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0332296:free [Functional Concept]
   748   C0441800:Grade [Classification]
   748   C0599638:WATER [Substance]
   748   C0919553:Grade [Classification]
   748   C1550678:Water [Inorganic Chemical]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C3244287:grade [Finding]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "(30-min argon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0003781:Argon [Element, Ion, or Isotope]
   827   C1948015:Argon [Eukaryote]
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "bubbled"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: ")"

Phrase: "with 1mM Desferal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.57: Desferal was used to decrease the spontaneous oxidation of hydroxylamines catalyzed by traces of transition metal ions. 

Phrase: "Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the spontaneous oxidation of hydroxylamines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "catalyzed by traces of transition metal ions."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0682906:transition metal [Element, Ion, or Isotope]
   757   C0723796:Trace metal [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0022023:Ions [Element, Ion, or Isotope]
   748   C0025552:Metal [Inorganic Chemical]
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C2700061:Transition [Activity]
   714   C0442822:Trace [Quantitative Concept]
   714   C1524031:Trace [Qualitative Concept]
   714 E C1700702:ION [Functional Concept]
   714   C1883002:Trace [Functional Concept]
Processing 00000000.tx.58: The concentration of TEMPONE-H in the stock solutions was 1mM. 

Phrase: "The concentration of TEMPONE-H"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in the stock solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "1mM."
Processing 00000000.tx.59: Prior to the experiments, the stock solution was kept under a flow of argon in a cool, air-tight place. 

Phrase: "Prior to the experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the stock solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "kept under a flow of argon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003781:Argon [Element, Ion, or Isotope]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C1948015:Argon [Eukaryote]
   719   C0333118:Keep [Functional Concept]

Phrase: "in a cool,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548792:Cool [Qualitative Concept]

Phrase: "air-tight place."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442504:Place [Spatial Concept]
   827   C1704765:Place [Functional Concept]
   827   C1882509:Place [Activity]
   827   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.60: Preparation of tert-Butylhydronitroxide Solution-- tert-Butylhydronitroxide was obtained by auto-oxidation of 1mM N-tert-butylhydroxylamine in water or by oxidation of 10M solution of N-tert-butylhydroxylamine with 10M K3[Fe(CN)6] in 0.15M phosphate buffer at pH 7.4. 

Phrase: "Preparation of tert-Butylhydronitroxide Solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "tert-Butylhydronitroxide"

Phrase: "was"

Phrase: "obtained by auto-oxidation of 1mM N-tert-butylhydroxylamine"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   753   C0311406:Increased auto-oxidation [Finding]
   742   C0030011:Oxidation [Molecular Function]
   742   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1301820:Obtained [Functional Concept]
   742   C1367342:TERT [Gene or Genome]
   742   C1441488:Auto [Laboratory Procedure]
   742   C1705316:TERT [Gene or Genome]
   708 E C1706701:Obtain [Activity]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "or by oxidation of 10M solution of N-tert-butylhydroxylamine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0030011:Oxidation [Molecular Function]
   739   C0037633:Solution [Substance]
   739   C0525069:Solution [Biomedical or Dental Material]
   739   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1367342:TERT [Gene or Genome]
   739   C1442446:10M [Temporal Concept]
   739   C1705316:TERT [Gene or Genome]

Phrase: "with 10M K3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416740:K3 [Gene or Genome]
   861   C2825157:K3 [Quantitative Concept]

Phrase: "[Fe(CN)6"

Phrase: "]"

Phrase: "in 0.15M phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.61: ESR Spin-trapping Experiments-- The ESR spectra were recorded using a Bruker ECS-106 spectrometer operating at 9.76GHz with a modulation frequency of 50kHz and a TM110 cavity. 

Phrase: "ESR Spin-trapping Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bruker ECS-106 spectrometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0183395:Spectrometer [Medical Device]
   812   C1710143:Spectrometer [Manufactured Object]

Phrase: "operating at 9.76GHz"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C3242339:operate [Functional Concept]

Phrase: "with a modulation frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "of 50kHz"

Phrase: "and"

Phrase: "a TM110 cavity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011334:cavity [Disease or Syndrome]
   861   C0333343:Cavity [Body Space or Junction]
   861   C1510420:Cavity [Anatomical Abnormality]
Processing 00000000.tx.62: Spin-trapping experiments were started by solubilizing A peptides into a solution of PBN or TEMPONE-H. 

Phrase: "Spin-trapping experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0282665:Spin Trapping [Laboratory Procedure]

Phrase: "were"

Phrase: "started by solubilizing A peptides"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1272689:Started [Qualitative Concept]
   726 E C0439659:Start [Temporal Concept]

Phrase: "into a solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "of PBN"

Phrase: "or"

Phrase: "TEMPONE-H."
Processing 00000000.tx.63: All ESR samples were placed in the 17-mm flat cell, which contained A peptides (1mg/ml), PBN (50mM), or TEMPONE-H (0.3mM) in sodium phosphate buffer (0.15M) at pH 7.4.In order to perform experiments with a lower concentration of transition metals, phosphate buffer was treated with 5g of Chelex-100/100 ml of solution for 2h, followed by filtration using Millex-HA 0.45-m filters (Millipore Corp., Bedford, MA). 

Phrase: "All ESR samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "placed in the 17-mm flat cell,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0007634:Cell [Cell]
   748   C0205324:Flat [Spatial Concept]
   748   C0457933:Flat [Manufactured Object]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "PBN (50mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450400:50mm [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "TEMPONE-H"

Phrase: "(0.3mM"

Phrase: ")"

Phrase: "in sodium phosphate buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(0.15M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442447:15M [Temporal Concept]

Phrase: ")"

Phrase: "at pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "experiments with a lower concentration of transition metals,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0681814:Experiments [Research Activity]
   711 E C1706386:Experiment [Conceptual Entity]

Phrase: "phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "treated with 5g of Chelex-100/100 ml of solution"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   739   C0037633:Solution [Substance]
   739   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   739   C0439526:/mL [Quantitative Concept]
   739   C0525069:Solution [Biomedical or Dental Material]
   739   C1522326:Treated [Functional Concept]
   706 E C1292734:TREAT [Functional Concept]

Phrase: "for 2h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "followed by filtration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0016107:filtration [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Millex-HA 0.45-m filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   799   C0180860:Filters [Manufactured Object]
   766 E C0581406:Filter [Medical Device]
   766 E C1522664:Filter [Intellectual Product]
   766 E C1704449:Filter [Conceptual Entity]
   766 E C1704684:Filter [Medical Device]
   766 E C1875155:FILTER [Medical Device]

Phrase: "(Millipore Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.64: The ESR instrumental settings for experiments with PBN were as follows: field sweep, 70G; 

Phrase: "The ESR instrumental settings for experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0542559:setting [Functional Concept]
   719   C1318139:{Setting} [Quantitative Concept]

Phrase: "with PBN"

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "field sweep,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348625:Sweep [Health Care Activity]

Phrase: "70G"

Phrase: ";"
Processing 00000000.tx.65: microwave frequency, 9.76GHz; 

Phrase: "microwave frequency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "9.76GHz"

Phrase: ";"
Processing 00000000.tx.66: microwave power, 40milliwatts; 

Phrase: "microwave power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "40milliwatts"

Phrase: ";"
Processing 00000000.tx.67: modulation amplitude, 0.32G; 

Phrase: "modulation amplitude,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "0.32G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2711872:32G [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.68: conversion time, 1310ms; 

Phrase: "conversion time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "1310ms"

Phrase: ";"
Processing 00000000.tx.69: time constant, 1310ms; 

Phrase: "time constant,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0040223:Time [Temporal Concept]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "1310ms"

Phrase: ";"
Processing 00000000.tx.70: receiver gain, 1105. 

Phrase: "receiver gain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517378:Gain [Quantitative Concept]

Phrase: "1105."
Processing 00000000.tx.71: ESR signals were monitored for 6h. 

Phrase: "ESR signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "monitored for 6h."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1292428:6H [Temporal Concept]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.72: The ESR instrumental settings for TEMPONE-H experiments were the following: field sweep, 50G; 

Phrase: "The ESR instrumental settings for TEMPONE-H experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0542559:setting [Functional Concept]
   714   C1318139:{Setting} [Quantitative Concept]

Phrase: "were"

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "field sweep,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348625:Sweep [Health Care Activity]

Phrase: "50G"

Phrase: ";"
Processing 00000000.tx.73: microwave frequency, 9.76GHz; 

Phrase: "microwave frequency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "9.76GHz"

Phrase: ";"
Processing 00000000.tx.74: microwave power, 20milliwatts; 

Phrase: "microwave power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "20milliwatts"

Phrase: ";"
Processing 00000000.tx.75: modulation amplitude, 1G; 

Phrase: "modulation amplitude,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "1G"

Phrase: ";"
Processing 00000000.tx.76: conversion time, 656ms; 

Phrase: "conversion time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "656ms"

Phrase: ";"
Processing 00000000.tx.77: time constant, 2620ms; 

Phrase: "time constant,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0040223:Time [Temporal Concept]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "2620ms"

Phrase: ";"
Processing 00000000.tx.78: receiver gain, 1105. 

Phrase: "receiver gain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517378:Gain [Quantitative Concept]

Phrase: "1105."
Processing 00000000.tx.79: Study of Iron-catalyzed Oxidation of Hydroxylamines-- The presence of hydroxylamine impurities in Sigma PBN was determined by studying iron's effect on nitroxide formation in solutions of PBN with K3[Fe(CN)6] and the iron-chelating agent Desferal. 

Phrase: "Study of Iron-catalyzed Oxidation of Hydroxylamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "The presence of hydroxylamine impurities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in Sigma PBN"

Phrase: "was"

Phrase: "determined by studying iron's effect"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]

Phrase: "on nitroxide formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "in solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "of PBN"

Phrase: "with K3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416740:K3 [Gene or Genome]
  1000   C2825157:K3 [Quantitative Concept]

Phrase: "[Fe(CN)6"

Phrase: "]"

Phrase: "and"

Phrase: "the iron-chelating agent Desferal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708   C0302583:Iron agent [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.80: Oxidation of hydroxylamine impurities in Sigma PBN was performed using 5M K3[Fe(CN)6]. 

Phrase: "Oxidation of hydroxylamine impurities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "in Sigma PBN"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5M K3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416740:K3 [Gene or Genome]
   861   C2825157:K3 [Quantitative Concept]

Phrase: "[Fe(CN)6"

Phrase: "]."
Processing 00000000.tx.81: Inhibition of iron-catalyzed oxidation of hydroxylamine impurities in Sigma PBN was carried out in the presence of 2mM Desferal. 

Phrase: "Inhibition of iron-catalyzed oxidation of hydroxylamine impurities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in Sigma PBN"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the presence of 2mM Desferal."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   776   C0442722:Present + out of +++ [Finding]
   776   C0442723:Present ++ out of +++ [Finding]
   776   C0442724:Present +++ out of +++ [Finding]
   776   C0442725:Present ++++ out of ++++ [Finding]
   776   C2724205:Present +++ out of ++++ [Finding]
   776   C2724207:Present + out of ++++ [Finding]
   776   C2724208:Present ++ out of ++++ [Finding]
   748   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.82: Study of Ferric-catalyzed Oxidation of Hydroxylamines-- The oxidation of TEMPONE-H by ferric ions was confirmed by the formation of TEMPONE nitroxide during the incubation of TEMPONE-H with ferric ions. 

Phrase: "Study of Ferric-catalyzed Oxidation of Hydroxylamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "The oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "by ferric ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0302583:ferric ion [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "was"

Phrase: "confirmed by the formation of TEMPONE nitroxide"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0878393:Tempone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "during the incubation"

Phrase: "of TEMPONE-H"

Phrase: "with ferric ions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0302583:ferric ion [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]
Processing 00000000.tx.83: The effect of 1M Fe(NH4)(SO4)2 and chelating agent Desferal on the TEMPONE nitroxide formation from 0.1mM TEMPONE-H was studied. 

Phrase: "The effect of 1M Fe(NH4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: "(SO4"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "chelating agent Desferal on the TEMPONE nitroxide formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "from 0.1mM TEMPONE-H"

Phrase: "was"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.84: Inhibition of iron-catalyzed oxidation of TEMPONE-H was carried out in the presence of 1mM Desferal, which has its highest affinity for ferric ion. 

Phrase: "Inhibition of iron-catalyzed oxidation of TEMPONE-H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the presence of 1mM Desferal,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   776   C0442722:Present + out of +++ [Finding]
   776   C0442723:Present ++ out of +++ [Finding]
   776   C0442724:Present +++ out of +++ [Finding]
   776   C0442725:Present ++++ out of ++++ [Finding]
   776   C2724205:Present +++ out of ++++ [Finding]
   776   C2724207:Present + out of ++++ [Finding]
   776   C2724208:Present ++ out of ++++ [Finding]
   748   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]

Phrase: "which"

Phrase: "has"

Phrase: "its highest affinity for ferric ion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.85: Study of Cupric-catalyzed Oxidation of Hydroxylamines-- The oxidation of TEMPONE-H by cupric ions was confirmed by the formation of TEMPONE nitroxide during the incubation of TEMPONE-H with cupric ions. 

Phrase: "Study of Cupric-catalyzed Oxidation of Hydroxylamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "The oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "by cupric ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "was"

Phrase: "confirmed by the formation of TEMPONE nitroxide"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0878393:Tempone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "during the incubation"

Phrase: "of TEMPONE-H"

Phrase: "with cupric ions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]
Processing 00000000.tx.86: In this experiment the effect of 1M CuSO4 and chelating agent Desferal on the TEMPONE nitroxide formation from 0.1mM TEMPONE-H was studied. 

Phrase: "In this experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the effect of 1M CuSO4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "chelating agent Desferal on the TEMPONE nitroxide formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "from 0.1mM TEMPONE-H"

Phrase: "was"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.87: Inhibition of cupric-catalyzed oxidation of TEMPONE-H was carried out in the presence of 1mM Desferal. 

Phrase: "Inhibition of cupric-catalyzed oxidation of TEMPONE-H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the presence of 1mM Desferal."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   776   C0442722:Present + out of +++ [Finding]
   776   C0442723:Present ++ out of +++ [Finding]
   776   C0442724:Present +++ out of +++ [Finding]
   776   C0442725:Present ++++ out of ++++ [Finding]
   776   C2724205:Present +++ out of ++++ [Finding]
   776   C2724207:Present + out of ++++ [Finding]
   776   C2724208:Present ++ out of ++++ [Finding]
   748   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.88: Computer Simulation-- Computer simulations and spin-trap data base searches were performed using a computer simulation program,2 the details of which have been described elsewhere (23).  

Phrase: "Computer Simulation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009609:Computer Simulation [Machine Activity]
   861   C0679083:Simulation [Research Activity]
   789 E C0284447:simulated [Biomedical or Dental Material]

Phrase: "--"

Phrase: "Computer simulations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009609:Simulations, Computer [Machine Activity]
   861   C0679083:simulations [Research Activity]
   777 E C0284447:simulated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "spin-trap data base searches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1552603:search [Intellectual Product]
   771   C1706202:Search [Activity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a computer simulation program,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0037585:Computer Program [Intellectual Product,Manufactured Object]
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C0009609:Computer Simulation [Machine Activity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "the details of which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1522508:Details [Qualitative Concept]
   737 E C1561567:detail [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.89: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Reinvestigation of Spontaneous Free Radical Formation by A Peptides-- The ability of A peptides to spontaneously form free radicals was studied by ESR using the spin trap PBN from the OMRF Spin Trap Source. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reinvestigation of Spontaneous Free Radical Formation"

Phrase: "by A Peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The ability of A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "to spontaneously"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "was"

Phrase: "studied by ESR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the spin trap PBN from the OMRF Spin Trap Source."
Processing 00000000.tx.90: A-(1-40), A-(40-1), and A-(25-35) peptides were tested in parallel with a control that did not contain A peptides (Fig. 1). 

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "in parallel with a control"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.91: ESR spectra were collected every 40min over 6h, and no ESR signals were observed in any mixtures (Fig. 1, A-D). 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every 40min over 6h,"

Phrase: "and"

Phrase: "no ESR signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "observed in any mixtures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439962:mixtures [Substance]
   770   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "D)."
Processing 00000000.tx.92: Therefore, A peptides do not form ESR-detectable radical adducts spontaneously. 

Phrase: "Therefore,"

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "ESR-detectable radical adducts spontaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596040:adducts [Chemical Viewed Structurally]
Processing 00000000.tx.93: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: ESR spectra of A with high quality OMRF PBN (A-D) or with Sigma PBN (E-H). 

Phrase: "ESR spectra of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1883073:Spectrum [Quantitative Concept]
   737   C2827424:Spectrum [Conceptual Entity]

Phrase: "with high quality OMRF PBN (A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "D)"

Phrase: "or with Sigma PBN (E-H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: A, ESR spectrum obtained after 6h of incubation of 50mM Sigma PBN in Chelex-100-treated 0.15M sodium-phosphate buffer (pH 7.4) without A peptides. 

Phrase: "A,"

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM Sigma PBN"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0450400:50mm [Quantitative Concept]
   742   C1292428:6H [Temporal Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1719918:Sigma [Intellectual Product]
   708 E C1706701:Obtain [Activity]

Phrase: "in Chelex-100-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "0.15M sodium-phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "without A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.97: B, ESR spectrum obtained after 6h of incubation of 50mM PBN with 1mg/ml A-(1-40). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0450400:50mm [Quantitative Concept]
   744   C1292428:6H [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.98: C, ESR spectrum obtained after 6h of incubation of 50mM PBN with 1mg/ml A-(40-1). 

Phrase: "C,"

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0450400:50mm [Quantitative Concept]
   744   C1292428:6H [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.99: D, ESR spectrum obtained after 6h of incubation of 50mM PBN with 1mg/ml A-(25-35). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0450400:50mm [Quantitative Concept]
   744   C1292428:6H [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")."
Processing 00000000.tx.100: E, ESR spectrum obtained after 6h of incubation of 50mM Sigma PBN in Chelex-100-treated 0.15M sodium-phosphate buffer (pH 7.4) without A peptides. 

Phrase: "E,"

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM Sigma PBN"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0450400:50mm [Quantitative Concept]
   742   C1292428:6H [Temporal Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1719918:Sigma [Intellectual Product]
   708 E C1706701:Obtain [Activity]

Phrase: "in Chelex-100-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "0.15M sodium-phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "without A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.101: F, ESR spectrum obtained after 6h of incubation of 50mM PBN with 1mg/ml A-(1-40). 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0450400:50mm [Quantitative Concept]
   744   C1292428:6H [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.102: G, ESR spectrum obtained after 6h of incubation of 50mM PBN with 1mg/ml A-(40-1). 

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0450400:50mm [Quantitative Concept]
   744   C1292428:6H [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.103: H, ESR spectrum obtained after 6h of incubation of 50mM PBN with 1mg/ml A-(25-35). 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 6h of incubation of 50mM PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0450400:50mm [Quantitative Concept]
   744   C1292428:6H [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")."
Processing 00000000.tx.104: In contrast to the OMRF PBN results, ESR spectra from mixtures of Sigma PBN alone, plus A-(1-40), plus A-(40-1), or plus A-(25-35) peptides all yielded a triplet ESR spectrum with the A peptide inhibiting radical formation (Fig. 1, E-H). 

Phrase: "In contrast to the OMRF PBN results,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0683954:research results [Finding]
   766   C1274040:Result [Functional Concept]
   766   C1546471:Result [Idea or Concept]
   766   C2825142:Result [Finding]

Phrase: "ESR spectra from mixtures of Sigma PBN alone, plus A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1883073:Spectrum [Quantitative Concept]
   706   C2827424:Spectrum [Conceptual Entity]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "plus A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or plus A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0332287:Plus [Qualitative Concept]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "all"

Phrase: "yielded"

Phrase: "a triplet ESR spectrum with the A peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "radical formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E-H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.105: This triplet spectrum has a nitrogen hyperfine-coupling constant of 17.14G.

Phrase: "This triplet spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "has"

Phrase: "a nitrogen hyperfine-coupling constant of 17.14G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1547014:*Constant [Quantitative Concept]
   744   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.106: The formation of this triplet spectrum with Sigma PBN, but not OMRF PBN, is consistent with the spectrum arising from an impurity in Sigma PBN. 

Phrase: "The formation of this triplet spectrum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "with Sigma PBN,"

Phrase: "but"

Phrase: "not OMRF PBN,"

Phrase: "is"

Phrase: "consistent with the spectrum arising"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "from an impurity"

Phrase: "in Sigma PBN."
Processing 00000000.tx.107: Formation of Di-tert-butylnitroxide and tert-Butylhydronitroxide from Impurities in Sigma PBN-- PBN from Sigma was checked for the presence of impurities that might lead to the formation of ESR signals. 

Phrase: "Formation of Di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "tert-Butylhydronitroxide from Impurities"

Phrase: "in Sigma PBN-- PBN"

Phrase: "from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "was"

Phrase: "checked for the presence of impurities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1283174:Checked [Activity]
   753   C2698670:IMPURITIES [Regulation or Law]

Phrase: "that"

Phrase: "might"

Phrase: "lead to the formation of ESR signals."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.108: After a 6-h incubation of 50mM aqueous Sigma PBN, a strong ESR spectrum was observed (Fig. 2A) that consisted of ESR spectra from two nitroxides (Fig. 2, B-D). 

Phrase: "After a 6-h incubation"

Phrase: "of 50mM aqueous Sigma PBN,"

Phrase: "a strong ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "that"

Phrase: "consisted of ESR spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0332529:CONSIST [Qualitative Concept]
   737   C1883073:Spectrum [Quantitative Concept]
   737   C2827424:Spectrum [Conceptual Entity]

Phrase: "from two nitroxides"

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D)."
Processing 00000000.tx.109: One nitroxide has a triplet ESR spectrum (Fig. 2C) with a nitrogen hyperfine coupling constant of 17.16G, which is very close to the reported nitrogen hyperfine coupling constant for di-tert-butylnitroxide. 

Phrase: "One nitroxide"

Phrase: "has"

Phrase: "a triplet ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "with a nitrogen hyperfine coupling constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1547014:*Constant [Quantitative Concept]
   812   C1948059:Constant [Qualitative Concept]

Phrase: "of 17.16G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456636:16G [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "close to the reported nitrogen hyperfine coupling constant"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0028158:Nitrogen [Element, Ion, or Isotope]
   744   C0587267:Close [Functional Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C1547014:*Constant [Quantitative Concept]
   744   C1550581:nitrogen [Human-caused Phenomenon or Process]
   744   C1948027:Coupling [Functional Concept]
   744   C1948059:Constant [Qualitative Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C0010222:couple [Family Group]
   711 E C3273238:Report [Intellectual Product]

Phrase: "for di-tert-butylnitroxide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]
Processing 00000000.tx.110: The second nitroxide has a four-line ESR spectrum (Fig. 2D) that is consistent with a nitrogen hyperfine coupling constant of 14.61G and a hydrogen hyperfine coupling constant of 13.93G, which are very close to the reported hyperfine coupling constants for tert-butylhydronitroxide (24, 25). 

Phrase: "The second nitroxide"

Phrase: "has"

Phrase: "a four-line ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1883073:Spectrum [Quantitative Concept]
   812   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "consistent with a nitrogen hyperfine coupling constant of 14.61G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "a hydrogen hyperfine coupling constant of 13.93G,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1547014:*Constant [Quantitative Concept]
   744   C1948059:Constant [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "close to the reported hyperfine coupling constants"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0587267:Close [Functional Concept]
   748   C0684224:Reported [Intellectual Product]
   748   C0700287:Reported [Health Care Activity]
   748   C1948027:Coupling [Functional Concept]
   748   C3496591:Reported [Clinical Attribute]
   714 E C0010222:couple [Family Group]
   714   C1547014:*Constant [Quantitative Concept]
   714   C1948059:Constant [Qualitative Concept]
   714 E C3273238:Report [Intellectual Product]

Phrase: "for tert-butylhydronitroxide"

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.111: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.113: Formation of di-tert-butylnitroxide and tert-butylhydronitroxide in an aqueous solution prepared using Sigma PBN. 

Phrase: "Formation of di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "tert-butylhydronitroxide in an aqueous solution"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sigma PBN."
Processing 00000000.tx.114: A, ESR spectrum obtained after a 6-h incubation of 50mM Sigma PBN. 

Phrase: "A,"

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after a 6-h incubation of 50mM Sigma PBN."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   757   C0444953:H 6 [Intellectual Product]
   739   C0033727:H+ [Element, Ion, or Isotope]
   739   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441932:H+ [Classification]
   739   C0450400:50mm [Quantitative Concept]
   739   C0564385:/h [Quantitative Concept]
   739   C1301820:Obtained [Functional Concept]
   739   C1719918:Sigma [Intellectual Product]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.115: B, computer simulation of A obtained by adding spectra of two nitroxides. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "computer simulation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0009609:Computer Simulation [Machine Activity]
   770   C0679083:Simulation [Research Activity]

Phrase: "obtained by adding spectra of two nitroxides."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0205448:Two [Quantitative Concept]
   748   C1301820:Obtained [Functional Concept]
   714 E C1706701:Obtain [Activity]
   714   C1883073:Spectrum [Quantitative Concept]
   714   C1883712:Add [Functional Concept]
   714   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.116: C, computer simulation of ESR spectrum of nitroxide with a nitrogen hyperfine coupling constant of 17.16G.D, simulation of ESR spectrum of nitroxide using hyperfine coupling constants of 14.61G for nitrogen and 13.93G for hydrogen. 

Phrase: "C,"

Phrase: "computer simulation of ESR spectrum of nitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0009609:Computer Simulation [Machine Activity]
   748   C0679083:Simulation [Research Activity]

Phrase: "with a nitrogen hyperfine coupling constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1547014:*Constant [Quantitative Concept]
   812   C1948059:Constant [Qualitative Concept]

Phrase: "of 17.16G.D,"

Phrase: "simulation of ESR spectrum of nitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679083:Simulation [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hyperfine coupling constants of 14.61G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1547014:*Constant [Quantitative Concept]
   719   C1948059:Constant [Qualitative Concept]

Phrase: "for nitrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028158:Nitrogen [Element, Ion, or Isotope]
  1000   C1550581:nitrogen [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "13.93G for hydrogen."
Processing 00000000.tx.117: E, ESR spectrum of 200nM di-tert-butylnitroxide. 

Phrase: "E,"

Phrase: "ESR spectrum of 200nM di-tert-butylnitroxide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883073:Spectrum [Quantitative Concept]
   748   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.118: F, ESR spectrum of tert-butylhydronitroxide from 10M N-(tert-butyl)hydroxylamine. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "ESR spectrum of tert-butylhydronitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883073:Spectrum [Quantitative Concept]
   760   C2827424:Spectrum [Conceptual Entity]

Phrase: "from 10M N-(tert-butyl"

Phrase: ")"

Phrase: "hydroxylamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020362:Hydroxylamine [Inorganic Chemical]
Processing 00000000.tx.119: To confirm the chemical structure of nitroxide radicals observed in the solution of Sigma PBN, we obtained experimental ESR spectra of di-tert-butylnitroxide (Fig. 2E) and tert-butylhydronitroxide (Fig. 2F). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the chemical structure of nitroxide radicals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0220807:Chemical Structure [Intellectual Product]
   753   C0220806:Chemical [Chemical]
   753   C0678594:Structure [Spatial Concept]
   753   C3272558:Chemical [Intellectual Product]

Phrase: "observed in the solution of Sigma PBN,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1441672:Observed [Functional Concept]
   748   C1719918:Sigma [Intellectual Product]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "experimental ESR spectra of di-tert-butylnitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 2E"

Phrase: ")"

Phrase: "and"

Phrase: "tert-butylhydronitroxide"

Phrase: "(Fig. 2F"

Phrase: ")."
Processing 00000000.tx.120: Experimental ESR spectra of di-tert-butylnitroxide and tert-butylhydronitroxide were identical to the ESR spectrum of the PBN solution shown above (Fig. 2). 

Phrase: "Experimental ESR spectra of di-tert-butylnitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "tert-butylhydronitroxide"

Phrase: "were"

Phrase: "identical to the ESR spectrum of the PBN solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205280:Identical [Qualitative Concept]

Phrase: "shown above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.121: The ESR spectra from the Sigma PBN solution (Fig. 2A) can be described as a combination of two specific ESR spectra: those of di-tert-butylnitroxide (Fig. 2E) and tert-butylhydronitroxide (Fig. 2F). 

Phrase: "The ESR spectra from the Sigma PBN solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "can"

Phrase: "be"

Phrase: "described as a combination of two specific ESR spectra"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0205195:Combination [Qualitative Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C1552738:described [Idea or Concept]
   742   C1552740:specific [Intellectual Product]
   742   C1947911:Combination [Physical Object]
   708   C1883073:Spectrum [Quantitative Concept]
   708   C2827424:Spectrum [Conceptual Entity]

Phrase: ":"

Phrase: "those of di-tert-butylnitroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1999927:tert-butylnitroxide [Organic Chemical]
   760   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1367342:TERT [Gene or Genome]
   760   C1705316:TERT [Gene or Genome]
   760   C3538902:DI [Gene or Genome]
   760   C3541881:DI [Idea or Concept]

Phrase: "(Fig. 2E"

Phrase: ")"

Phrase: "and"

Phrase: "tert-butylhydronitroxide"

Phrase: "(Fig. 2F"

Phrase: ")."
Processing 00000000.tx.122: Thus, during the incubation of Sigma PBN in water, both di-tert-butylnitroxide and tert-butylhydronitroxide were formed. 

Phrase: "Thus,"

Phrase: "during the incubation"

Phrase: "of Sigma PBN"

Phrase: "in water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "both di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "and"

Phrase: "tert-butylhydronitroxide"

Phrase: "were"

Phrase: "formed."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]
Processing 00000000.tx.123: In order to analyze the mechanism of nitroxide formation in the PBN solution, the effects of the chelating agent Desferal and of ferric iron addition were studied. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "analyze"

Phrase: "the mechanism of nitroxide formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in the PBN solution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "the effects of the chelating agent Desferal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and of ferric iron addition"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2346593:Ferric Iron [Element, Ion, or Isotope]
           Ferric
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]
   760   C1883712:Addition [Functional Concept]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.124: Fresh solutions of Sigma PBN in Chelex-100-treated phosphate buffer contained trace amounts of di-tert-butylnitroxide as identified by its ESR spectrum (Fig. 3A). 

Phrase: "Fresh solutions of Sigma PBN"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0037633:Solutions [Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "in Chelex-100-treated phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "trace amounts of di-tert-butylnitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0442822:trace amount [Quantitative Concept]
   753   C1265611:amounts [Quantitative Concept]

Phrase: "as"

Phrase: "identified by its ESR spectrum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1883073:Spectrum [Quantitative Concept]
   760   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.125: After just 2h of incubation, the ESR signal was increased dramatically (Fig. 3B). 

Phrase: "After"

Phrase: "just 2h of incubation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1292425:2H [Temporal Concept]

Phrase: "the ESR signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "dramatically"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.126: A parallel 2-h incubation in the presence of the chelating agent Desferal significantly inhibited formation of di-tert-butylnitroxide (Fig. 3C). 

Phrase: "A parallel 2-h incubation in the presence"

Phrase: "of the chelating agent Desferal significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "formation of di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: Addition of 5mM K3[Fe(CN)6] to the fresh PBN solution caused greater nitroxide formation (Fig. 3D) than that of the 2-h incubation (Fig. 3B). 

Phrase: "Addition of 5mM K3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "[Fe(CN)6"

Phrase: "]"

Phrase: "to the fresh PBN solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "greater nitroxide formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: "than that"

Phrase: "of the 2-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.128: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.130: Formation of di-tert-butylnitroxide during transition metal-catalyzed auto-oxidation of di-tert-butylhydroxylamine in a solution of Sigma PBN. 

Phrase: "Formation of di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "during transition metal-catalyzed auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   804   C0030011:Oxidation [Molecular Function]
   804   C1441488:Auto [Laboratory Procedure]

Phrase: "of di-tert-butylhydroxylamine"

Phrase: "in a solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "of Sigma PBN."
Processing 00000000.tx.131: A, ESR spectrum obtained after 10min of incubation of 50mM Sigma PBN in Chelex-100-treated phosphate buffer. 

Phrase: "A,"

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 10min of incubation of 50mM Sigma PBN"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   742   C0450400:50mm [Quantitative Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1719918:Sigma [Intellectual Product]
   708 E C1706701:Obtain [Activity]

Phrase: "in Chelex-100-treated phosphate buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.132: B, ESR spectrum obtained after 2h of incubation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 2h of incubation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1292425:2H [Temporal Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.133: C, ESR spectrum obtained after 2h of incubation of 50mM Sigma PBN with 2mM Desferal; 

Phrase: "C,"

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after 2h of incubation of 50mM Sigma PBN"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0450400:50mm [Quantitative Concept]
   742   C1292425:2H [Temporal Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1719918:Sigma [Intellectual Product]
   708 E C1706701:Obtain [Activity]

Phrase: "with 2mM Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.134: D, ESR spectrum obtained after addition of 5M K3[Fe(CN)6] to A. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "ESR spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after addition of 5M K3"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C1301820:Obtained [Functional Concept]
   753   C1416740:K3 [Gene or Genome]
   753   C1883712:Addition [Functional Concept]
   753   C2825157:K3 [Quantitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "[Fe(CN)6"

Phrase: "]"

Phrase: "to A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.135: Linewidth Dependence on the ESR Instrumental Settings-- Previously, it was reported that A-(1-40) and A-(25-35) peptides formed radical adducts with identical triplet ESR spectra and nitrogen hyperfine coupling constants of 17.1G (16), which is actually the same as that reported for di-tert-butylnitroxide (Fig. 2E). 

Phrase: "Linewidth Dependence on the ESR Instrumental Settings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011546:Dependence [Mental Process]
   748   C0439857:Dependence [Mental or Behavioral Dysfunction]
   748   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "--"

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "radical adducts with identical triplet ESR spectra"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "nitrogen hyperfine coupling constants of 17.1G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547014:*Constant [Quantitative Concept]
   714   C1948059:Constant [Qualitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "actually"

Phrase: "the same as that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "reported for di-tert-butylnitroxide"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1999927:tert-butylnitroxide [Organic Chemical]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1367342:TERT [Gene or Genome]
   760   C1705316:TERT [Gene or Genome]
   760   C3496591:Reported [Clinical Attribute]
   760   C3538902:DI [Gene or Genome]
   760   C3541881:DI [Idea or Concept]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.136: Based on the much greater linewidth of the A peptide/PBN reaction product (1.6G), these authors concluded that this product was not di-tert-butylnitroxide (17). 

Phrase: "Based on the much greater linewidth of the A peptide/PBN reaction product"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   735   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0011560:Amyloid [Pathologic Function]
   735   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   735   C0443228:greater [Quantitative Concept]
   735   C0443286:Reaction [Functional Concept]
   735   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C1114821:Reaction [Clinical Attribute]
   735   C1514468:product [Entity]
   735   C1527178:Based [Functional Concept]
   735   C1704243:Greater [Quantitative Concept]
   735   C1704444:Product [Quantitative Concept]
   735   C1705938:Based [Idea or Concept]
   732   C0360301:Product base [Organic Chemical,Pharmacologic Substance]
   702 E C0002055:base [Inorganic Chemical]
   702 E C0178499:Base [Chemical Viewed Functionally]
   702 E C0549177:Great [Quantitative Concept]
   702 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(1.6G"

Phrase: ")"

Phrase: ","

Phrase: "these authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "this product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "not di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.137: However, the linewidth is not a specific parameter of a nitroxide ESR spectrum (26). 

Phrase: "However,"

Phrase: "the linewidth"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a specific parameter of a nitroxide ESR spectrum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0549193:Parameter [Spatial Concept]
   744   C1704769:Parameter [Conceptual Entity]
   744   C2350001:Parameter [Quantitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.138: Linewidth is very dependent on the ESR instrumental settings, mainly modulation amplitude and microwave power. 

Phrase: "Linewidth"

Phrase: "is"

Phrase: "very dependent on the ESR instrumental settings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "mainly modulation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "microwave power."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]
Processing 00000000.tx.139: In order to show that authentic di-tert-butylnitroxide and the nitroxide derived from Sigma PBN can have the same ESR linewidth as has been described for a PBN/A peptide radical adduct, the ESR spectra were obtained using different modulation amplitude settings (Fig. 4). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that authentic di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "and"

Phrase: "the nitroxide"

Phrase: "derived from Sigma PBN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441547:Derived [Qualitative Concept]
   770   C1719918:Sigma [Intellectual Product]
   770   C3245521:derived [Idea or Concept]

Phrase: "can"

Phrase: "have"

Phrase: "the same ESR linewidth"

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "described for a PBN/A peptide radical adduct,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0302912:Radical [Chemical Viewed Structurally]
   744   C0439807:Radical [Qualitative Concept]
   744   C0596040:adduct [Chemical Viewed Structurally]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1552738:described [Idea or Concept]

Phrase: "the ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different modulation amplitude settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0542559:setting [Functional Concept]
   779   C1318139:{Setting} [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.140: The linewidth of the ESR spectra of di-tert-butylnitroxide was equal to that of the nitroxide from Sigma PBN (Fig. 4, A and D) when ESR spectra were collected under identical instrument settings. 

Phrase: "The linewidth of the ESR spectra of di-tert-butylnitroxide"

Phrase: "was"

Phrase: "equal to that of the nitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205163:Equal To [Qualitative Concept]
           Equal
   753   C1549782:Equal [Idea or Concept]

Phrase: "from Sigma PBN (Fig. 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1719918:Sigma [Intellectual Product]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "D)"

Phrase: "when"

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "collected under identical instrument settings."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205280:Identical [Qualitative Concept]
   760   C0348000:Instrument [Medical Device]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726   C0542559:setting [Functional Concept]
   726   C1318139:{Setting} [Quantitative Concept]
Processing 00000000.tx.141: Moreover, both spectra displayed the same linewidth dependence on the modulation amplitude setting. 

Phrase: "Moreover,"

Phrase: "both spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the same linewidth dependence on the modulation amplitude setting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0011546:Dependence [Mental Process]
   742   C0439857:Dependence [Mental or Behavioral Dysfunction]
   742   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.142: We observed peak-to-peak linewidths of 0.51,0.96,and 1.56G when using modulation amplitudes of 0.32,1.00,and 1.59G, respectively (Fig. 4). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "peak-to-peak linewidths of 0.51,"

Phrase: "0.96,"

Phrase: "and"

Phrase: "1.56G"

Phrase: "when"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "modulation amplitudes of 0.32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2346753:Amplitude [Spatial Concept]

Phrase: "1.00,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1.59G,"

Phrase: "respectively"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.143: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 4.  

Phrase: "4."
Processing 00000000.tx.145: Dependence of ESR spectra of di-tert-butylnitroxide on modulation amplitude. 

Phrase: "Dependence of ESR spectra of di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0011546:Dependence [Mental Process]
   744   C0439857:Dependence [Mental or Behavioral Dysfunction]
   744   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on modulation amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.146: ESR spectra of 50mM Sigma PBN after 6h of incubation in Chelex-100-treated phosphate buffer using the following modulation amplitudes: A, 0.32G; 

Phrase: "ESR spectra of 50mM Sigma PBN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "after 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "of incubation"

Phrase: "in Chelex-100-treated phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following modulation amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2346753:Amplitude [Spatial Concept]

Phrase: ":"

Phrase: "A,"

Phrase: "0.32G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2711872:32G [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.147: B, 1.00G; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "1.00G"

Phrase: ";"
Processing 00000000.tx.148: C, 1.59G.ESR spectra of 200nM di-tert-butylnitroxide using the following modulation amplitudes: D, 0.32G; 

Phrase: "C,"

Phrase: "1.59G.ESR spectra of 200nM di-tert-butylnitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1883073:Spectrum [Quantitative Concept]
   708   C2827424:Spectrum [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following modulation amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2346753:Amplitude [Spatial Concept]

Phrase: ":"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "0.32G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2711872:32G [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.149: E, 1.00G; 

Phrase: "E,"

Phrase: "1.00G"

Phrase: ";"
Processing 00000000.tx.150: F, 1.59G. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "1.59G."
Processing 00000000.tx.151: Previously, it was also reported that non-toxic A-(40-1) peptide formed a radical adduct with a quartet ESR spectrum and equivalent nitrogen and hydrogen hyperfine coupling constants of 14.5G (16, 17), which are very close to those reported for tert-butylhydronitroxide (Fig. 2F). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that non-toxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a radical adduct with a quartet ESR spectrum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596040:adduct [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "equivalent nitrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028158:Nitrogen [Element, Ion, or Isotope]
   861   C1550581:nitrogen [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "hydrogen hyperfine coupling constants of 14.5G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547014:*Constant [Quantitative Concept]
   714   C1948059:Constant [Qualitative Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "close to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "reported for tert-butylhydronitroxide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1367342:TERT [Gene or Genome]
   770   C1705316:TERT [Gene or Genome]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(Fig. 2F"

Phrase: ")."
Processing 00000000.tx.152: Based on the much greater linewidth of the PBN/A peptide reaction product, it was concluded that this product was not tert-butylhydronitroxide (17). 

Phrase: "Based on the much greater linewidth"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0443228:greater [Quantitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1704243:Greater [Quantitative Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0549177:Great [Quantitative Concept]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "of the PBN/A peptide reaction product,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "this product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "not tert-butylhydronitroxide"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.153: In order to show that tert-butylhydronitroxide and the nitroxide from Sigma PBN solution could have the same ESR spectrum linewidth as the radical described as the PBN/A peptide-(1-40) reaction product, the ESR spectra were obtained using different modulation amplitude settings for the ESR spectrometer (Fig. 5). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that tert-butylhydronitroxide"

Phrase: "and"

Phrase: "the nitroxide from Sigma PBN solution"

Phrase: "could"

Phrase: "have"

Phrase: "the same ESR spectrum linewidth as the radical"

Phrase: "described as the PBN/A peptide-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1552738:described [Idea or Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "reaction product,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "the ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different modulation amplitude settings for the ESR spectrometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0542559:setting [Functional Concept]
   711   C1318139:{Setting} [Quantitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.154: The linewidth of the ESR spectrum of tert-butylhydronitroxide was the same as for the nitroxide species from the Sigma PBN solution (Fig. 5, A and D). 

Phrase: "The linewidth of the ESR spectrum of tert-butylhydronitroxide"

Phrase: "was"

Phrase: "the same as for the nitroxide species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1278655:SAME AS [Classification]
   748   C0445247:Same [Qualitative Concept]

Phrase: "from the Sigma PBN solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.155: Moreover, the dependence of linewidth on the modulation amplitude was the same. 

Phrase: "Moreover,"

Phrase: "the dependence of linewidth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011546:Dependence [Mental Process]
   770   C0439857:Dependence [Mental or Behavioral Dysfunction]
   770   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on the modulation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "the same."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.156: Using modulation amplitudes of 0.32,1.00,and 1.59G, the widths of the low-field line were observed to be 0.76,0.98,and 1.53G, respectively (Fig. 5). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "modulation amplitudes of 0.32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2346753:Amplitude [Spatial Concept]

Phrase: "1.00,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1.59G,"

Phrase: "the widths of the low-field line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0487742:Width [Quantitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "0.76,"

Phrase: "0.98,"

Phrase: "and"

Phrase: "1.53G,"

Phrase: "respectively"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.157: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.159: Dependence of ESR spectra of tert-butylhydronitroxide on modulation amplitude. 

Phrase: "Dependence of ESR spectra of tert-butylhydronitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011546:Dependence [Mental Process]
   748   C0439857:Dependence [Mental or Behavioral Dysfunction]
   748   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on modulation amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.160: ESR spectra of 50mM Sigma PBN after 6h of incubation in phosphate buffer using the following modulation amplitudes: A, 0.32G; 

Phrase: "ESR spectra of 50mM Sigma PBN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "after 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "of incubation"

Phrase: "in phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following modulation amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2346753:Amplitude [Spatial Concept]

Phrase: ":"

Phrase: "A,"

Phrase: "0.32G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2711872:32G [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.161: B, 1.00G; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "1.00G"

Phrase: ";"
Processing 00000000.tx.162: C, 1.59G.ESR spectra of tert-butylhydronitroxide using the following modulation amplitudes: D, 0.32G; 

Phrase: "C,"

Phrase: "1.59G.ESR spectra of tert-butylhydronitroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following modulation amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2346753:Amplitude [Spatial Concept]

Phrase: ":"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "0.32G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2711872:32G [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.163: E, 1.00G; 

Phrase: "E,"

Phrase: "1.00G"

Phrase: ";"
Processing 00000000.tx.164: F, 1.59G. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "1.59G."
Processing 00000000.tx.165: A Peptide Stimulation of Oxidation of Di-tert-butylhydroxylamine Impurity in Sigma PBN-- The ability of A peptides to stimulate oxidation of di-tert-butylhydroxylamine was studied by ESR using PBN from Sigma. 

Phrase: "A Peptide Stimulation of Oxidation of Di-tert-butylhydroxylamine Impurity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in Sigma PBN--"

Phrase: "The ability of A peptides to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "oxidation of di-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "studied by ESR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PBN from Sigma."
Processing 00000000.tx.166: For these experiments, solutions of A-(1-40), A-(25-35), and A-(40-1) with 50mM PBN and 1mM Desferal were tested in parallel with a control that did not contain A peptides (Fig. 6). 

Phrase: "For these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "solutions of A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0037633:Solutions [Substance]
   756 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "with 50mM PBN"

Phrase: "and"

Phrase: "1mM Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "in parallel with a control"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.167: Incubation of PBN (Sigma) with A peptides for 2h in phosphate buffer with Desferal gave rise to the ESR spectra shown in Fig. 

Phrase: "Incubation of PBN (Sigma"

Phrase: ")"

Phrase: "with A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "in phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to the ESR spectra"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.168: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.169: Neurotoxic A-(1-40) and A-(25-35) produced triplet ESR spectra (Fig. 6, A and B) in agreement with Butterfield and co-workers (14-17). 

Phrase: "Neurotoxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "produced triplet ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B) in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "with Butterfield"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(14-17"

Phrase: ")."
Processing 00000000.tx.170: Computer simulation of these ESR spectra (Fig. 6) revealed an ESR spectrum of one nitroxide compound which displays a triplet ESR spectrum with a nitrogen hyperfine coupling constant of 17.16G, which is identical to the nitrogen hyperfine coupling constant for di-tert-butylnitroxide. 

Phrase: "Computer simulation of these ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0009609:Computer Simulation [Machine Activity]
   753   C0679083:Simulation [Research Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an ESR spectrum of one nitroxide compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883073:Spectrum [Quantitative Concept]
   748   C2827424:Spectrum [Conceptual Entity]

Phrase: "which"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a triplet ESR spectrum with a nitrogen hyperfine coupling constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1883073:Spectrum [Quantitative Concept]
   739   C2827424:Spectrum [Conceptual Entity]

Phrase: "of 17.16G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456636:16G [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "identical to the nitrogen hyperfine coupling constant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "for di-tert-butylnitroxide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]
Processing 00000000.tx.171: Non-toxic A-(40-1) produced a much weaker nitroxide triplet and the four-line tert-butylhydronitroxide (Fig. 6C). 

Phrase: "Non-toxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "produced"

Phrase: "a much weaker nitroxide triplet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041095:Triplet [Family Group]
   812   C0205174:Triplet [Quantitative Concept]

Phrase: "and"

Phrase: "the four-line tert-butylhydronitroxide"

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.172: ESR spectra of a control sample without A peptides did not reveal any nitroxide formation (Fig. 6D). 

Phrase: "ESR spectra of a control sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "without A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any nitroxide formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 6D"

Phrase: ")."
Processing 00000000.tx.173: Under these conditions the formation of this triplet spectrum with Sigma PBN was dependent on the presence of toxic A-(1-40) and A-(25-35). 

Phrase: "Under these"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "the formation of this triplet spectrum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "with Sigma PBN"

Phrase: "was"

Phrase: "dependent on the presence of toxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")."
Processing 00000000.tx.174: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.175: 6.  

Phrase: "6."
Processing 00000000.tx.176: Formation of di-tert-butylnitroxide during the incubation of A peptides with Sigma PBN. 

Phrase: "Formation of di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "during the incubation"

Phrase: "of A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with Sigma PBN."
Processing 00000000.tx.177: ESR spectra obtained after a 2-hr incubation of 50mM PBN in 0.15M sodium phosphate buffer (pH 7.4) plus 1mM Desferal: A, with 1mg/ml A-(1-40); 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after a 2-hr incubation of 50mM PBN"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0450400:50mm [Quantitative Concept]
   742   C1301820:Obtained [Functional Concept]
   708 E C1706701:Obtain [Activity]

Phrase: "in 0.15M sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "plus 1mM Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ":"

Phrase: "A,"

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.178: B, with 1mg/ml A-(25-35); 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.179: C, with 1mg/ml A-(40-1); 

Phrase: "C,"

Phrase: "with 1mg/ml A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.180: D, without A. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "without A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.181: ESR receiver gain was 5105. 

Phrase: "ESR receiver gain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "5105."
Processing 00000000.tx.182: It was previously shown that di-tert-butylnitroxide can be formed in a solution of PBN by the metal-catalyzed auto-oxidation of di-tert-butylhydroxylamine. 

Phrase: "It"

Phrase: "was"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "can"

Phrase: "be"

Phrase: "formed in a solution of PBN"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0037633:Solution [Substance]
   753   C0205431:Formed [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "by the metal-catalyzed auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   812   C0030011:Oxidation [Molecular Function]
   812   C1441488:Auto [Laboratory Procedure]

Phrase: "of di-tert-butylhydroxylamine."
Processing 00000000.tx.183: Therefore, in the presence of 1mM Desferal in phosphate buffer, A-(1-40) and A-(25-35) stimulate the oxidation of the di-tert-butylhydroxylamine impurity to form di-tert-butylnitroxide. 

Phrase: "Therefore,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1mM Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "stimulate"

Phrase: "the oxidation of the di-tert-butylhydroxylamine impurity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030011:Oxidation [Molecular Function]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "di-tert-butylnitroxide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]
Processing 00000000.tx.184: A-stimulated Oxidation of TEMPONE-H-- In order to study the mechanism of A-stimulated hydroxylamine oxidation, we used TEMPONE-H (22). 

Phrase: "A-stimulated Oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the mechanism of A-stimulated hydroxylamine oxidation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TEMPONE-H"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.185: The time course of ESR spectra and the effect of removing transition metals from the phosphate buffer by treatment with chelating resin Chelex-100 were studied. 

Phrase: "The time course of ESR spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the effect of removing transition metals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "from the phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with chelating resin Chelex-100"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0035191:Resin [Biomedical or Dental Material]
   812   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   812   C3537131:Chelating [Molecular Function]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.186: TEMPONE-H was incubated with A peptides in phosphate buffer with 1mM Desferal (Fig. 7). 

Phrase: "TEMPONE-H"

Phrase: "was"

Phrase: "incubated with A peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 1mM Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.187: It was found that after a 1-h incubation of TEMPONE-H (0.3mM) with A-(25-35) and A-(1-40), the ESR amplitude of TEMPONE nitroxide increased up to 4times in comparison with the control (Fig. 7, A, B, and D). 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "after"

Phrase: "a 1-h incubation of TEMPONE-H"

Phrase: "(0.3mM"

Phrase: ")"

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "the ESR amplitude of TEMPONE nitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "increased up to 4times"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.188: Incubation of TEMPONE-H (0.3mM) with A-(40-1) increased the ESR amplitude in the range of 50-100% compared with the control (Fig. 7 C, D). 

Phrase: "Incubation of TEMPONE-H"

Phrase: "(0.3mM"

Phrase: ")"

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the ESR amplitude in the range of 50-100%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2346753:Amplitude [Spatial Concept]

Phrase: "compared with the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 7 C,"

Phrase: "D)."
Processing 00000000.tx.189: Therefore, neurotoxic A-(1-40) and A-(25-35) significantly stimulated oxidation of TEMPONE-H to TEMPONE nitroxide (Fig. 7, A and B). 

Phrase: "Therefore,"

Phrase: "neurotoxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "significantly stimulated oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "to TEMPONE nitroxide"

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.190: Non-toxic A-(40-1) caused relatively minor changes in the formation of TEMPONE nitroxide (Fig. 7C) compared with a control sample without A peptides (Fig. 7D). 

Phrase: "Non-toxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "relatively minor changes in the formation of TEMPONE nitroxide"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "(Fig. 7C"

Phrase: ")"

Phrase: "compared with a control sample"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0243148:control [Qualitative Concept]
   760   C0370003:Sample [Substance]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2347026:Sample [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "without A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 7D"

Phrase: ")."
Processing 00000000.tx.191: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.192: 7.  

Phrase: "7."
Processing 00000000.tx.193: Effect of A peptides on the TEMPONE formation during transition metal-catalyzed oxidation of TEMPONE-H. 

Phrase: "Effect of A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the TEMPONE formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "during transition metal-catalyzed oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:Oxidation [Molecular Function]

Phrase: "of TEMPONE-H."
Processing 00000000.tx.194: A-D, 0.15M sodium phosphate buffer plus 1mM Desferal (DF). 

Phrase: "A-D,"

Phrase: "0.15M sodium phosphate buffer plus 1mM Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(DF"

Phrase: ")."
Processing 00000000.tx.195: E-H, Chelex-100-treated 0.15M sodium phosphate buffer plus 1mM DF. 

Phrase: "E-H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chelex-100-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "0.15M sodium phosphate buffer plus 1mM DF."
Processing 00000000.tx.196: ESR spectra obtained after a 1-h incubation of 0.3mM TEMPONE-H with A (1mg/ml). 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after a 1-h incubation of 0.3mM TEMPONE-H"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   757   C0700308:h 1 [Element, Ion, or Isotope]
   739   C0033727:H+ [Element, Ion, or Isotope]
   739   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441932:H+ [Classification]
   739   C0564385:/h [Quantitative Concept]
   739   C1301820:Obtained [Functional Concept]
   706 E C1706701:Obtain [Activity]

Phrase: "with A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.197: ESR receiver gain was 1105. 

Phrase: "ESR receiver gain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "1105."
Processing 00000000.tx.198: In order to clarify the role of transition metals in A-mediated stimulation of hydroxylamine oxidation, phosphate buffer was pretreated for 1h with chelating resin Chelex-100 to remove trace-metal contaminants. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the role of transition metals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in A-mediated stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of hydroxylamine oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "pretreated for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442450:1H [Temporal Concept]

Phrase: "with chelating resin Chelex-100 to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0035191:Resin [Biomedical or Dental Material]
   804   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   804   C3537131:Chelating [Molecular Function]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "trace-metal contaminants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C2827365:Contaminant [Substance]
   734   C0723796:Trace metal [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.199: ESR spectra obtained after the incubation of TEMPONE-H (0.3mM) with A peptides in Chelex-100-treated phosphate buffer are shown in Fig. 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after the incubation of TEMPONE-H"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(0.3mM"

Phrase: ")"

Phrase: "with A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Chelex-100-treated phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.200: 7, E-H. 

Phrase: "7,"

Phrase: "E-H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.201: In Chelex-100-treated phosphate buffer, A peptides did not stimulate oxidation of TEMPONE-H, implying that A peptides were not the primary source of trace transition metals. 

Phrase: "In Chelex-100-treated phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stimulate"

Phrase: "oxidation of TEMPONE-H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "implying"

Phrase: "that A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the primary source of trace transition metals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449416:Source [Finding]
   748   C1705919:Source [Idea or Concept]
Processing 00000000.tx.202: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 8 shows the time dependence of TEMPONE formation during the incubation of TEMPONE-H with A peptides. 

Phrase: "8"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the time dependence of TEMPONE formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "during the incubation"

Phrase: "of TEMPONE-H"

Phrase: "with A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.204: Formation of TEMPONE nitroxide in the samples with A-(1-40) and A-(25-35) was significantly faster than with A-(40-1) and in the control (Fig. 8A). 

Phrase: "Formation of TEMPONE nitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "in the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "was"

Phrase: "significantly faster than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and in the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.205: Removing transition metals from the solution by pretreatment of phosphate buffer with Chelex-100 strongly inhibited A stimulation of TEMPONE formation (Fig. 8B). 

Phrase: "Removing transition metals from the solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0682906:transition metal [Element, Ion, or Isotope]
   753   C0025552:Metals [Inorganic Chemical]
   753   C0599156:Transition [Cell or Molecular Dysfunction]
   753   C2700061:Transition [Activity]

Phrase: "by pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "of phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with Chelex-100 strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A stimulation of TEMPONE formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.206: Therefore, in phosphate buffer with 1mM Desferal, A-(1-40) and A-(25-35) enhanced TEMPONE-H oxidation, which was inhibited by Chelex-100 treatment. 

Phrase: "Therefore,"

Phrase: "in phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 1mM Desferal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "enhanced TEMPONE-H oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "which"

Phrase: "was"

Phrase: "inhibited by Chelex-100 treatment."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0039798:treatment [Functional Concept]
   760   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.207: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.208: 8.  

Phrase: "8."
Processing 00000000.tx.209: Time course of TEMPONE formation during incubation of TEMPONE-H with A peptides (1mg/ml). 

Phrase: "Time course of TEMPONE formation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0449247:Time course [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0750729:Course [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "during incubation"

Phrase: "of TEMPONE-H"

Phrase: "with A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.210: A, formation of TEMPONE in 0.15M sodium phosphate buffer plus 1mM Desferal. 

Phrase: "A,"

Phrase: "formation of TEMPONE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "in 0.15M sodium phosphate buffer plus 1mM Desferal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.211: B, formation of TEMPONE in Chelex-100-treated 0.15M sodium phosphate buffer plus 1mM Desferal. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "formation of TEMPONE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "in Chelex-100-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "0.15M sodium phosphate buffer plus 1mM Desferal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.212: Effect of Ferric Ions on TEMPONE-H Oxidation-- The potential role of ferric ion in A-stimulated hydroxylamine oxidation was studied (Fig. 9). 

Phrase: "Effect of Ferric Ions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on TEMPONE-H Oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "The potential role of ferric ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in A-stimulated hydroxylamine oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.213: ESR spectra of the fresh solution of TEMPONE-H revealed only a relatively small amount of TEMPONE (Fig. 9A). 

Phrase: "ESR spectra of the fresh solution of TEMPONE-H"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a relatively small amount of TEMPONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.214: Addition of 1M Fe3+NH4(SO4)2 to TEMPONE-H led to a 10-fold increase in the ESR amplitude of the TEMPONE spectra (Fig. 9B). 

Phrase: "Addition of 1M Fe3+NH4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "(SO4"

Phrase: ")"

Phrase: "2 to TEMPONE-H"

Phrase: "led to a 10-fold increase"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1708698:LED [Manufactured Object]
   753   C1880834:FOLD [Phenomenon or Process]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the ESR amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "of the TEMPONE spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.215: The chelating agent Desferal (1mM) completely inhibited oxidation of TEMPONE-H in solutions containing 1M Fe3+NH4(SO4)2 (Fig. 9C). 

Phrase: "The chelating agent Desferal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   734   C0007974:Chelating agent [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1mM"

Phrase: ")"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "in solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1M Fe3+NH4"

Phrase: "(SO4"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(Fig. 9C"

Phrase: ")."
Processing 00000000.tx.216: Therefore, ferric ion can oxidize hydroxylamine TEMPONE-H to form nitroxide TEMPONE and, presumably, ferrous ion (Reaction 1), which is air-oxidized (Reaction 2) (27). 

Phrase: "Therefore,"

Phrase: "ferric ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:ferric ion [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "can"

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "hydroxylamine TEMPONE-H to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "nitroxide TEMPONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0878393:Tempone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "presumably,"

Phrase: "ferrous ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "(Reaction 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "air-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001861:Air [Substance]
  1000   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   916 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "(Reaction 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.217: Hydrogen peroxide did not directly oxidize the hydroxylamine TEMPONE-H in solution containing Desferal (data not shown). 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "did"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "the hydroxylamine TEMPONE-H in solution containing Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.218: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.219: 9.  

Phrase: "9."
Processing 00000000.tx.220: Effect of ferric ion on TEMPONE-H oxidation. 

Phrase: "Effect of ferric ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on TEMPONE-H oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.221: A, control. 

Phrase: "A,"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.222: B, in the presence of 1M Fe3+NH4(SO4)2; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M Fe3+NH4"

Phrase: "(SO4"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.223: C, in the presence of 1M Desferal plus 1M Fe3+NH4(SO4)2. 

Phrase: "C,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M Desferal plus 1M Fe3+NH4"

Phrase: "(SO4"

Phrase: ")"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.224: ESR spectra were recorded after a 20-min incubation. 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded after a 20-min incubation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0702093:/min [Temporal Concept]
   719   C0034869:Record [Intellectual Product]
Processing 00000000.tx.225: ESR receiver gain was 1105. 

Phrase: "ESR receiver gain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "1105."
Processing 00000000.tx.226: Effect of Cupric Ions on TEMPONE-H Oxidation-- The possible role of cupric ions in A-stimulated hydroxylamine oxidation was studied (Fig. 10). 

Phrase: "Effect of Cupric Ions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on TEMPONE-H Oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "The possible role of cupric ions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in A-stimulated hydroxylamine oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.227: Addition of 1M Cu2+SO4 to TEMPONE-H led to a drastic increase in the ESR amplitude of the TEMPONE spectrum (Fig. 10, A, and D), which was much more pronounced than the effect of 1M Fe3+NH4(SO4)2 (Fig. 10B). 

Phrase: "Addition of 1M Cu2+SO4 to TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "led to a drastic increase"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the ESR amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "of the TEMPONE spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "much more"

Phrase: "pronounced than the effect of 1M Fe3+NH4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0470296:1M [Quantitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2346593:Fe3+ [Element, Ion, or Isotope]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(SO4"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(Fig. 10B"

Phrase: ")."
Processing 00000000.tx.228: The chelating agent Desferal (1mM) completely inhibited oxidation of TEMPONE-H by 1M Cu2+SO4 (Fig. 10C). 

Phrase: "The chelating agent Desferal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   734   C0007974:Chelating agent [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1mM"

Phrase: ")"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "by 1M Cu2+SO4"

Phrase: "(Fig. 10C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422424:10C [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.229: Therefore, cupric ion can oxidize hydroxylamine TEMPONE-H to form nitroxide TEMPONE and cuprous ion (Reaction 3), which is oxidized by oxygen (Reaction 4) (28). 

Phrase: "Therefore,"

Phrase: "cupric ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "can"

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "hydroxylamine TEMPONE-H to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "nitroxide TEMPONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0878393:Tempone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cuprous ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0056602:cuprous ion [Inorganic Chemical]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "(Reaction 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "oxidized by oxygen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   756   C0030011:oxidize [Molecular Function]

Phrase: "(Reaction 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.230: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.231: 10.  

Phrase: "10."
Processing 00000000.tx.232: Effect of cupric ion on TEMPONE-H oxidation. 

Phrase: "Effect of cupric ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on TEMPONE-H oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.233: A, in the presence of 1M Cu2+SO4. 

Phrase: "A,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M Cu2+SO4."
Processing 00000000.tx.234: B, in the presence of 1M Fe3+NH4(SO4)2. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M Fe3+NH4"

Phrase: "(SO4"

Phrase: ")"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.235: C, in the presence of 1mM Desferal plus 1M Cu2+SO4. 

Phrase: "C,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1mM Desferal plus 1M Cu2+SO4."
Processing 00000000.tx.236: D, control. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.237: ESR spectra were recorded after a 20-min incubation. 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded after a 20-min incubation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0702093:/min [Temporal Concept]
   719   C0034869:Record [Intellectual Product]
Processing 00000000.tx.238: ESR receiver gain was 1104. 

Phrase: "ESR receiver gain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "1104."
Processing 00000000.tx.239: Auto-oxidation of Hydroxylamines-- In order to clarify the mechanism of auto-oxidation of hydroxylamine derivatives, formation of TEMPONE was determined in the presence of superoxide dismutase, catalase, or Desferal (Fig. 11). 

Phrase: "Auto-oxidation of Hydroxylamines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   770   C0030011:Oxidation [Molecular Function]
   770   C1441488:Auto [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the mechanism of auto-oxidation of hydroxylamine derivatives,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "formation of TEMPONE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "determined in the presence of superoxide dismutase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0038836:Superoxide [Element, Ion, or Isotope]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "or"

Phrase: "Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.240: TEMPONE-H was incubated in phosphate buffer for 30min. 

Phrase: "TEMPONE-H"

Phrase: "was"

Phrase: "incubated in phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   770   C0031701:phosphate [Organophosphorus Compound]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 30min."
Processing 00000000.tx.241: ESR spectra of the control sample of TEMPONE-H revealed a small amount of TEMPONE (Fig. 11A). 

Phrase: "ESR spectra of the control sample of TEMPONE-H"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a small amount of TEMPONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(Fig. 11A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553643:11a [Medical Device]

Phrase: ")."
Processing 00000000.tx.242: The addition of superoxide dismutase (100units/ml) to TEMPONE-H led to a 2-fold decrease in the ESR amplitude of the TEMPONE spectra (Fig. 11B). 

Phrase: "The addition of superoxide dismutase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "(100units/ml) to TEMPONE-H"

Phrase: "led to a 2-fold decrease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   767   C2346661:Lead 2+ [Element, Ion, or Isotope]
   753   C0332462:Fold [Spatial Concept]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   753   C1708698:LED [Manufactured Object]
   753   C1880834:FOLD [Phenomenon or Process]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the ESR amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "of the TEMPONE spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 11B"

Phrase: ")."
Processing 00000000.tx.243: The effect of superoxide dismutase supports the role of Reaction 5in the auto-oxidation of hydroxylamines (22). 

Phrase: "The effect of superoxide dismutase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the role of Reaction 5in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the auto-oxidation of hydroxylamines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   760   C0030011:Oxidation [Molecular Function]
   760   C1441488:Auto [Laboratory Procedure]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.244: Addition of catalase (10g) to TEMPONE-H did not significantly change the content of TEMPONE in the sample (Fig. 11C). 

Phrase: "Addition of catalase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "(10g"

Phrase: ")"

Phrase: "to TEMPONE-H"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the content of TEMPONE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "in the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 11C"

Phrase: ")."
Processing 00000000.tx.245: Addition of the chelating agent Desferal (100M) to TEMPONE-H greatly inhibited the TEMPONE formation (Fig. 11D). 

Phrase: "Addition of the chelating agent Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "(100M"

Phrase: ")"

Phrase: "to TEMPONE-H greatly"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the TEMPONE formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 11D"

Phrase: ")."
Processing 00000000.tx.246: Therefore, transition metals (Mn+1) can oxidize hydroxylamine TEMPONE-H to form TEMPONE (Reaction 6). 

Phrase: "Therefore,"

Phrase: "transition metals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0682906:transition metal [Element, Ion, or Isotope]
   861   C0025552:Metals [Inorganic Chemical]
   861   C0599156:Transition [Cell or Molecular Dysfunction]
   861   C2700061:Transition [Activity]
   789 E C1182674:Transitional [Spatial Concept]
   789 E C1548597:Transitional [Idea or Concept]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "(Mn+1"

Phrase: ")"

Phrase: "can"

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "hydroxylamine TEMPONE-H to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "TEMPONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878393:Tempone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(Reaction 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.247: Reduced transition metals (Mn+) are oxidized by oxygen (Reaction 7). 

Phrase: "Reduced transition metals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   867   C0682906:transition metal [Element, Ion, or Isotope]
   827   C0025552:Metals [Inorganic Chemical]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C2700061:Transition [Activity]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]
   743 E C2986473:Metallic [Qualitative Concept]

Phrase: "(Mn+)"

Phrase: "are"

Phrase: "oxidized by oxygen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   756   C0030011:oxidize [Molecular Function]

Phrase: "(Reaction 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.248: Decomposition of hydrogen peroxide by catalase did not affect the oxidation of hydroxylamine TEMPONE-H, excluding a role for a direct oxidation of TEMPONE-H by hydrogen peroxide. 

Phrase: "Decomposition of hydrogen peroxide"

Phrase: "by catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the oxidation of hydroxylamine TEMPONE-H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "a role for a direct oxidation of TEMPONE-H"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "by hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.249: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.250: 11.  

Phrase: "11."
Processing 00000000.tx.251: Formation of TEMPONE nitroxide during the auto-oxidation of TEMPONE-H. 

Phrase: "Formation of TEMPONE nitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "during the auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   861   C0030011:Oxidation [Molecular Function]
   861   C1441488:Auto [Laboratory Procedure]

Phrase: "of TEMPONE-H."
Processing 00000000.tx.252: ESR spectra obtained after a 30-min incubation of 0.1mM TEMPONE-H in 0.15M sodium phosphate buffer (pH 7.4). 

Phrase: "ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained after a 30-min incubation of 0.1mM TEMPONE-H"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0456693:/30 min [Temporal Concept]
   760   C1442458:30 min [Temporal Concept]
   739   C0702093:/min [Temporal Concept]
   739   C1301820:Obtained [Functional Concept]
   706 E C1706701:Obtain [Activity]

Phrase: "in 0.15M sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.253: A, control. 

Phrase: "A,"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.254: B, TEMPONE-H (0.1mM)+SOD (100units/ml). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "TEMPONE-H"

Phrase: "(0.1mM"

Phrase: ")"

Phrase: "+SOD"

Phrase: "(100units/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.255: C, TEMPONE-H (0.1mM)+catalase (10g/ml). 

Phrase: "C,"

Phrase: "TEMPONE-H"

Phrase: "(0.1mM"

Phrase: ")"

Phrase: "+catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.256: D, TEMPONE-H (0.1mM)+Desferal (0.1mM). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TEMPONE-H"

Phrase: "(0.1mM"

Phrase: ")"

Phrase: "+Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(0.1mM"

Phrase: ")."
Processing 00000000.tx.257: ESR receiver gain was 2105.  

Phrase: "ESR receiver gain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "2105."
Processing 00000000.tx.258: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Despite many studies on A peptide-mediated neurotoxicity, its exact mechanism of action is still undefined. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES Despite many studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   802   C2985663:Study Reference [Intellectual Product]
   770   C0947630:studies [Laboratory Procedure]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "on A peptide-mediated neurotoxicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "its exact mechanism of action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0031327:mechanism of action [Physiologic Function]
   862   C1524059:mechanism of action [Functional Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "still undefined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750600:undefined [Idea or Concept]
Processing 00000000.tx.259: One intriguing hypothesis suggests that A peptides in solution spontaneously form free radicals which damage and kill cells (14, 15). 

Phrase: "One intriguing hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A peptides in solution spontaneously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "which"

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "kill cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.260: We did not observe any radical adducts when the A peptides A(1-40), A-(40-1), and A-(25-35) were mixed with high quality PBN (OMRF Spin Trap Source). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any radical adducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "when"

Phrase: "the A peptides A"

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "were"

Phrase: "mixed with high quality PBN (OMRF Spin Trap Source"
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   753   C0079816:Medical Research [Research Activity]
   753   C1556038:Medical Research [Professional or Occupational Group]
   751   C0814847:quality research [Research Activity]
   736   C0016617:Foundation [Organization]
   736   C0028914:Oklahoma [Geographic Area]
   736   C0035168:research [Research Activity]
   736   C0184047:trap [Medical Device]
   736   C0205250:High [Qualitative Concept]
   736   C0205430:Mixed [Functional Concept]
   736   C0205476:Medical [Functional Concept]
   736   C0242481:Research [Research Activity]
   736   C0297331:TR-AP [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0332306:Quality [Qualitative Concept]
   736   C0449416:Source [Finding]
   736   C1299351:High [Qualitative Concept]
   736   C1336677:TR-AP [Gene or Genome]
   736   C1415347:SPIN [Gene or Genome]
   736   C1705919:Source [Idea or Concept]
   736   C1710330:TR-AP [Gene or Genome]
   736   C1823107:SPIN [Gene or Genome]
   736   C2700149:HIGH [Intellectual Product]
   736   C3160715:Mixed [Finding]
   711   C2986512:Research Base [Organization]
   703 E C1421951:MIX [Gene or Genome]
   703 E C1720722:Mix [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.261: Previously, it was reported that ESR signals formed during the incubation of A peptides with PBN were due to PBN/A peptide radical adducts (14-17). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that ESR signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "formed during the incubation of A peptides"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0205431:Formed [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "with PBN"

Phrase: "were due to PBN/A peptide radical adducts"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0302912:Radical [Chemical Viewed Structurally]
   744   C0439807:Radical [Qualitative Concept]
   744   C0596040:adducts [Chemical Viewed Structurally]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3146286:Due [Idea or Concept]

Phrase: "(14-17"

Phrase: ")."
Processing 00000000.tx.262: However, according to the current literature, there are no reported radical adducts of PBN that have similar ESR parameters (aN=17.1G). 

Phrase: "However,"

Phrase: "according to the current literature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023866:Literature [Intellectual Product]
   861   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "there"

Phrase: "are"

Phrase: "no reported radical adducts of PBN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "have"

Phrase: "similar ESR parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0449381:Parameters [Finding]
   793 E C0549193:Parameter [Spatial Concept]
   793 E C1704769:Parameter [Conceptual Entity]
   793 E C2350001:Parameter [Quantitative Concept]

Phrase: "("

Phrase: "aN=17.1G"

Phrase: ")."
Processing 00000000.tx.263: Using Sigma PBN, both the triplet and quartet spectra of di-tert-butyl- and tert-butylhydronitroxides, respectively, were detected. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sigma PBN,"

Phrase: "both"

Phrase: "the triplet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041095:Triplet [Family Group]
  1000   C0205174:Triplet [Quantitative Concept]

Phrase: "and"

Phrase: "quartet spectra of di-tert-butyl-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "tert-butylhydronitroxides,"

Phrase: "respectively,"

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.264: These nitroxides had previously been misinterpreted as novel radical adducts formed from A radicals (14-17). 

Phrase: "These nitroxides"

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "misinterpreted as novel radical adducts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205314:Novel [Temporal Concept]
   760   C0302912:Radical [Chemical Viewed Structurally]
   760   C0439807:Radical [Qualitative Concept]
   760   C0596040:adducts [Chemical Viewed Structurally]
   760   C0679622:novel [Intellectual Product]

Phrase: "formed from A radicals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0205431:Formed [Functional Concept]
   770   C0302912:radicals [Chemical Viewed Structurally]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C0439807:Radical [Qualitative Concept]
   737 E C1522492:Form [Functional Concept]

Phrase: "(14-17"

Phrase: ")."
Processing 00000000.tx.265: Recently, it was suggested that PBN/A peptide radical adducts decomposed to an alkoxyl nitroxide (15, 17). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PBN/A peptide radical adducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "decomposed to an alkoxyl nitroxide"

Phrase: "(15,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.266: This alkoxyl nitroxide would have the same structure as the alkoxyl adduct of 2-methyl-2-nitrosopropane. 

Phrase: "This alkoxyl nitroxide"

Phrase: "would"

Phrase: "have"

Phrase: "the same structure as the alkoxyl adduct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]

Phrase: "of 2-methyl-2-nitrosopropane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076165:2-methyl-2-nitrosopropane [Organic Chemical]
Processing 00000000.tx.267: This assignment is also an error, because the nitrogen hyperfine coupling constant of alkoxyl adducts of 2-methyl-2-nitrosopropane is about 27G (29, 30), which is quite different from the 17.1G for the radical observed. 

Phrase: "This assignment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516050:Assignment [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "an error,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0743559:error [Qualitative Concept]
  1000   C1608199:Error [Functional Concept]

Phrase: "because"

Phrase: "the nitrogen hyperfine coupling constant of alkoxyl adducts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1547014:*Constant [Quantitative Concept]
   744   C1948059:Constant [Qualitative Concept]

Phrase: "of 2-methyl-2-nitrosopropane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076165:2-methyl-2-nitrosopropane [Organic Chemical]

Phrase: "is"

Phrase: "about 27G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456640:27G [Quantitative Concept]

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "quite different from the 17.1G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "for the radical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302912:Radical [Chemical Viewed Structurally]
  1000   C0439807:Radical [Qualitative Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.268: Moreover, according to the data base (http://epr.niehs.nih.gov/), the hyperfine coupling constant of 17.1G is very specific to di-tert-butylnitroxide, which is directly supported by the ESR experiments with synthetic di-tert-butylnitroxide presented here (Fig. 2E). 

Phrase: "Moreover,"

Phrase: "according to the data base"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0242356:Database [Intellectual Product]
  1000   C0993637:Data Base [Intellectual Product]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1511726:Data [Idea or Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   861   C3245479:data [Medical Device]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//epr.niehs.nih.gov/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1419208:GOV [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the hyperfine coupling constant of 17.1G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1547014:*Constant [Quantitative Concept]
   748   C1948059:Constant [Qualitative Concept]

Phrase: "is"

Phrase: "very specific to di-tert-butylnitroxide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "supported by the ESR experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0681814:Experiments [Research Activity]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "with synthetic di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.269: We show in this work that these ESR signals do not appear during the incubation of A peptides with high quality OMRF PBN. 

Phrase: "We"

Phrase: "show in this work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   770   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "these ESR signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear during the incubation of A peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0700364:APPEAR [Qualitative Concept]

Phrase: "with high quality OMRF PBN."
Processing 00000000.tx.270: Moreover, these ESR signals did appear during the auto-oxidation of impurities only in the Sigma PBN. 

Phrase: "Moreover,"

Phrase: "these ESR signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "did"

Phrase: "appear during the auto-oxidation of impurities only"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   744   C0030011:Oxidation [Molecular Function]
   744   C0205171:Only [Quantitative Concept]
   744   C0700364:APPEAR [Qualitative Concept]
   744   C1441488:Auto [Laboratory Procedure]
   744   C1720467:Only [Intellectual Product]
   744   C2698670:IMPURITIES [Regulation or Law]

Phrase: "in the Sigma PBN."
Processing 00000000.tx.271: These data strongly suggest that the ESR spectra reported as PBN/A peptide radical adducts actually result from the formation of di-tert-butylnitroxide and tert-butylhydronitroxide radicals. 

Phrase: "These data strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "reported as PBN/A peptide radical adducts actually"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0302912:Radical [Chemical Viewed Structurally]
   744   C0439807:Radical [Qualitative Concept]
   744   C0596040:adducts [Chemical Viewed Structurally]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "result from the formation of di-tert-butylnitroxide"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1999927:tert-butylnitroxide [Organic Chemical]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1274040:Result [Functional Concept]
   744   C1367342:TERT [Gene or Genome]
   744   C1522492:Formation [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1705316:TERT [Gene or Genome]
   744   C2825142:Result [Finding]
   744   C3538902:DI [Gene or Genome]
   744   C3541881:DI [Idea or Concept]

Phrase: "and"

Phrase: "tert-butylhydronitroxide radicals."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0302912:radicals [Chemical Viewed Structurally]
   793 E C0439807:Radical [Qualitative Concept]
Processing 00000000.tx.272: These nitroxide radicals are formed during metal-catalyzed auto-oxidation of di-tert-butylhydroxylamine and N-tert-butylhydroxylamine (Scheme 1), which are impurities in PBN from Sigma. 

Phrase: "These nitroxide radicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0302912:radicals [Chemical Viewed Structurally]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "are"

Phrase: "formed during metal-catalyzed auto-oxidation of di-tert-butylhydroxylamine"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   760   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   739   C0025552:Metal [Inorganic Chemical]
   739   C0030011:Oxidation [Molecular Function]
   739   C0205431:Formed [Functional Concept]
   739   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1367342:TERT [Gene or Genome]
   739   C1441488:Auto [Laboratory Procedure]
   739   C1705316:TERT [Gene or Genome]
   739   C3538902:DI [Gene or Genome]
   739   C3541881:DI [Idea or Concept]
   706 E C0348078:Form [Qualitative Concept]
   706 E C0376315:Form [Manufactured Object]
   706 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "N-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649604:N-tert-butylhydroxylamine [Organic Chemical]

Phrase: "(Scheme 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "impurities in PBN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2698670:IMPURITIES [Regulation or Law]

Phrase: "from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.273: View larger version (10K): [in this window] [in a new window]  Scheme 1.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Scheme 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.274: The spin trap PBN is usually synthesized by condensation of benzaldehyde with N-tert-butylhydroxylamine (31). 

Phrase: "The spin trap PBN"

Phrase: "is"

Phrase: "usually"

Phrase: "synthesized by condensation of benzaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005023:benzaldehyde [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0233656:Condensation [Mental or Behavioral Dysfunction]
   760   C0598405:condensation [Natural Phenomenon or Process]
   760   C1883254:Synthesized [Activity]

Phrase: "with N-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649604:N-tert-butylhydroxylamine [Organic Chemical]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.275: Therefore, the trace amount of N-tert-butylhydroxylamine in preparations of PBN is probably due to incomplete purification. 

Phrase: "Therefore,"

Phrase: "the trace amount of N-tert-butylhydroxylamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0442822:trace amount [Quantitative Concept]
   748   C1265611:Amount [Quantitative Concept]

Phrase: "in preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "of PBN"

Phrase: "is"

Phrase: "probably due to incomplete purification."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0205257:Incomplete [Quantitative Concept]
   760   C0243114:purification [Functional Concept]
   760   C0728938:incomplete [Quantitative Concept]
   760   C0750492:Probably [Idea or Concept]
   760   C1548386:incomplete [Idea or Concept]
   760   C1998793:Purification [Functional Concept]
   760   C3146286:Due [Idea or Concept]
Processing 00000000.tx.276: The appearance of di-tert-butylhydroxylamine in PBN can be explained by the presence of di-tert-butylhydroxylamine in the N-tert-butylhydroxylamine commonly used for the synthesis of PBN. 

Phrase: "The appearance of di-tert-butylhydroxylamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "in PBN"

Phrase: "can"

Phrase: "be"

Phrase: "explained by the presence of di-tert-butylhydroxylamine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1367342:TERT [Gene or Genome]
   744   C1705316:TERT [Gene or Genome]
   744   C3538902:DI [Gene or Genome]
   744   C3541881:DI [Idea or Concept]

Phrase: "in the N-tert-butylhydroxylamine commonly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   923   C0649604:N-tert-butylhydroxylamine [Organic Chemical]

Phrase: "used for the synthesis of PBN."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0220781:synthesis [Biologic Function]
   753   C1273517:used [Finding]
   753   C1883254:Synthesis [Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.277: Scheme 2 illustrates the mechanism of di-tert-butylhydroxylamine formation from N-tert-butylhydroxylamine. 

Phrase: "Scheme 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]

Phrase: "illustrates"

Phrase: "the mechanism of di-tert-butylhydroxylamine formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "from N-tert-butylhydroxylamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649604:N-tert-butylhydroxylamine [Organic Chemical]
Processing 00000000.tx.278: N-tert-butylhydroxylamine is a good reducing agent, which, after two one-electron oxidations, produces 2-methyl-2-nitrosopropane. 

Phrase: "N-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649604:N-tert-butylhydroxylamine [Organic Chemical]

Phrase: "is"

Phrase: "a good reducing agent,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0376446:reducing agent [Indicator, Reagent, or Diagnostic Aid]
   827   C0392756:Reducing [Qualitative Concept]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "which,"

Phrase: "after"

Phrase: "two one-electron oxidations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:oxidations [Molecular Function]

Phrase: "produces"

Phrase: "2-methyl-2-nitrosopropane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076165:2-methyl-2-nitrosopropane [Organic Chemical]
Processing 00000000.tx.279: 2-Methyl-2-nitrosopropane is an unstable compound, which is readily decomposed by heat or light to the tert-butyl radical and nitric oxide (32, 33). 

Phrase: "2-Methyl-2-nitrosopropane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076165:2-methyl-2-nitrosopropane [Organic Chemical]

Phrase: "is"

Phrase: "an unstable compound,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "which"

Phrase: "is"

Phrase: "readily"

Phrase: "decomposed by heat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "light to the tert-butyl radical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C1306462:Light [Functional Concept]
   753   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.280: The tert-butyl radical will react with 2-methyl-2-nitrosopropane (which is actually a well known spin trap) to form di-tert-butylnitroxide (32, 33). 

Phrase: "The tert-butyl radical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0302912:Radical [Chemical Viewed Structurally]
   827   C0439807:Radical [Qualitative Concept]

Phrase: "will"

Phrase: "react with 2-methyl-2-nitrosopropane"

Phrase: "("

Phrase: "which"

Phrase: "is"

Phrase: "actually"

Phrase: "a well known spin trap) to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0184047:trap [Medical Device]
   804   C0297331:TR-AP [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1336677:TR-AP [Gene or Genome]
   804   C1710330:TR-AP [Gene or Genome]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.281: Di-tert-butylnitroxide can easily be reduced to di-tert-butylhydroxylamine even by excess N-tert-butylhydroxylamine. 

Phrase: "Di-tert-butylnitroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1999927:tert-butylnitroxide [Organic Chemical]

Phrase: "can"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "be"

Phrase: "reduced to di-tert-butylhydroxylamine even"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0392756:Reduced [Qualitative Concept]
   753   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1367342:TERT [Gene or Genome]
   753   C1705316:TERT [Gene or Genome]
   753   C3538902:DI [Gene or Genome]
   753   C3541881:DI [Idea or Concept]

Phrase: "by excess N-tert-butylhydroxylamine."
Processing 00000000.tx.282: The presence of di-tert-butylhydroxylamine in the sample of N-tert-butylhydroxylamine was supported by the fact that the ESR spectra of N-tert-butylhydroxylamine oxidized by K3[Fe(CN)6] contained small traces of the triplet signal of di-tert-butylnitroxide (Fig. 3F). 

Phrase: "The presence of di-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "of N-tert-butylhydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649604:N-tert-butylhydroxylamine [Organic Chemical]

Phrase: "was"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "the ESR spectra of N-tert-butylhydroxylamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "oxidized by K3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1416740:K3 [Gene or Genome]
   790   C2825157:K3 [Quantitative Concept]
   756   C0030011:oxidize [Molecular Function]

Phrase: "[Fe(CN)6"

Phrase: "]"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "small traces of the triplet signal of di-tert-butylnitroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0442822:Trace [Quantitative Concept]
   706   C1524031:Trace [Qualitative Concept]
   706   C1883002:Trace [Functional Concept]

Phrase: "(Fig. 3F"

Phrase: ")."
Processing 00000000.tx.283: Therefore, trace amounts of di-tert-butylhydroxylamine are present in many preparations of PBN. 

Phrase: "Therefore,"

Phrase: "trace amounts of di-tert-butylhydroxylamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0442822:trace amount [Quantitative Concept]
   753   C1265611:amounts [Quantitative Concept]

Phrase: "are"

Phrase: "present in many preparations of PBN."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.284: Due to the intrinsic sensitivity of ESR, oxidation of trace levels of these impurities can lead to readily detected ESR signals. 

Phrase: "Due to the intrinsic sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "of ESR,"

Phrase: "oxidation of trace levels of these impurities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "can"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to readily detected ESR signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.285: The assignment of the structure of these nitroxides to specific compounds excludes the possibility that these ESR spectra are derived from amyloid peptides. 

Phrase: "The assignment of the structure of these nitroxides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516050:Assignment [Functional Concept]

Phrase: "to specific compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "these ESR spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "are"

Phrase: "derived from amyloid peptides."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.286: View larger version (7K): [in this window] [in a new window]  Scheme 2.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(7K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Scheme 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.287: In this work we investigated the effect of neurotoxic A-(1-40) and A-(25-35) and non-toxic A-(40-1) on the oxidation of hydroxylamine derivatives. 

Phrase: "In this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of neurotoxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0235032:Neurotoxic effect [Injury or Poisoning]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "and"

Phrase: "non-toxic A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "on the oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of hydroxylamine derivatives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.288: We previously showed that, in the presence of Desferal, incubation of A-(1-40) and A-(25-35) with PBN (Sigma) led to the formation of di-tert-butylnitroxide, which was produced after oxidation of di-tert-butylhydroxylamine. 

Phrase: "We previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of Desferal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "incubation of A-"

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "with PBN (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "led to the formation of di-tert-butylnitroxide,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   770   C1999927:tert-butylnitroxide [Organic Chemical]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1367342:TERT [Gene or Genome]
   744   C1522492:Formation [Functional Concept]
   744   C1705316:TERT [Gene or Genome]
   744   C1708698:LED [Manufactured Object]
   744   C3538902:DI [Gene or Genome]
   744   C3541881:DI [Idea or Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "was"

Phrase: "produced after oxidation of di-tert-butylhydroxylamine."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030011:Oxidation [Molecular Function]
   748   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1367342:TERT [Gene or Genome]
   748   C1705316:TERT [Gene or Genome]
   748   C3538902:DI [Gene or Genome]
   748   C3541881:DI [Idea or Concept]
Processing 00000000.tx.289: Stimulation of oxidation of hydroxylamine derivatives by A-(1-40) or A-(25-35) was also demonstrated using TEMPONE-H. 

Phrase: "Stimulation of oxidation of hydroxylamine derivatives"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TEMPONE-H."
Processing 00000000.tx.290: Oxidation of TEMPONE-H to TEMPONE nitroxide in the presence of A-(1-40) or A-(25-35) was significantly more intensive than in the control without A. 

Phrase: "Oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "to TEMPONE nitroxide"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "was"

Phrase: "significantly more intensive than"

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "without A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.291: The treatment of phosphate buffer with chelating resin Chelex-100 inhibits the A effect on TEMPONE-H oxidation. 

Phrase: "The treatment of phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with chelating resin Chelex-100"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0035191:Resin [Biomedical or Dental Material]
   812   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   812   C3537131:Chelating [Molecular Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the A effect on TEMPONE-H oxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.292: These data support a catalytic role of phosphate buffer-derived transition metal contaminants in the A-stimulated oxidation of hydroxylamine derivatives. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a catalytic role of phosphate buffer-derived transition metal contaminants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in the A-stimulated oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "of hydroxylamine derivatives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.293: It is known that ferricyanide is able to oxidize hydroxylamine derivatives (34). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that ferricyanide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015864:ferricyanide [Inorganic Chemical]
  1000   C0117554:ferricyanide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "hydroxylamine derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.294: Cupric ion is another candidate for the oxidation of hydroxylamines. 

Phrase: "Cupric ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "is"

Phrase: "another candidate for the oxidation of hydroxylamines."
Processing 00000000.tx.295: In this work we checked the possible role of both ferric and cupric ions in oxidation of hydroxylamine derivatives. 

Phrase: "In this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "we"

Phrase: "checked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Checked [Activity]

Phrase: "the possible role of both ferric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "cupric ions in oxidation of hydroxylamine derivatives."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   748   C0022023:Ions [Element, Ion, or Isotope]
   714 E C1700702:ION [Functional Concept]
Processing 00000000.tx.296: It was found that both ferric and cupric ions were effective in oxidation of TEMPONE-H. 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both ferric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346593:Ferric [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "cupric ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "were"

Phrase: "effective in oxidation of TEMPONE-H."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.297: Moreover, oxidation of TEMPONE-H by cupric ions was 40-fold more effective than ferric ions. 

Phrase: "Moreover,"

Phrase: "oxidation of TEMPONE-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "by cupric ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "was"

Phrase: "40-fold more effective than ferric ions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.298: Therefore, both ferric and cupric ions could be involved in A-stimulated metal-catalyzed oxidation of hydroxylamine derivatives. 

Phrase: "Therefore,"

Phrase: "both ferric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346593:Ferric [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "cupric ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1177210:Cupric Ion [Inorganic Chemical,Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "involved in A-stimulated metal-catalyzed oxidation of hydroxylamine derivatives."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0020362:Hydroxylamine [Inorganic Chemical]
   739   C0025552:Metal [Inorganic Chemical]
   739   C0030011:Oxidation [Molecular Function]
   739   C0243072:derivatives [Chemical Viewed Structurally]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1314939:Involved [Functional Concept]
   739   C1948023:Stimulated [Natural Phenomenon or Process]
   706 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.299: The data obtained allow us to conclude that, under some conditions, the toxic A peptides A-(1-40) and A-(25-35) enhance transition metal-catalyzed oxidation of hydroxylamine derivatives. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that,"

Phrase: "under some conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the toxic A peptides A-"

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "transition metal-catalyzed oxidation of hydroxylamine derivatives."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.300: Therefore, the previously reported formation of radical adducts with A peptides can be explained as an A-enhanced, transition metal-catalyzed oxidation of hydroxylamine derivatives found as impurities in commercial PBN. 

Phrase: "Therefore,"

Phrase: "the previously reported formation of radical adducts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "with A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "explained as an A-enhanced, transition metal-catalyzed oxidation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0682906:transition metal [Element, Ion, or Isotope]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0025552:Metal [Inorganic Chemical]
   742   C0030011:Oxidation [Molecular Function]
   742   C0599156:Transition [Cell or Molecular Dysfunction]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C2349975:Enhanced [Activity]
   742   C2700061:Transition [Activity]

Phrase: "of hydroxylamine derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "found as impurities"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C2698670:IMPURITIES [Regulation or Law]
   756 E C0243095:Find [Finding]

Phrase: "in commercial PBN."
Processing 00000000.tx.301: In addition, our data (Fig. 7) demonstrate that A peptides can compete with Desferal for transition metals such as copper, which implies that A peptides may bind redox-active transition metals in vivo where trace metal concentrations are extremely low. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "demonstrate"

Phrase: "that A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "compete with Desferal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for transition metals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0682906:transition metal [Element, Ion, or Isotope]
   861   C0025552:Metals [Inorganic Chemical]
   861   C0599156:Transition [Cell or Molecular Dysfunction]
   861   C2700061:Transition [Activity]
   789 E C1182674:Transitional [Spatial Concept]
   789 E C1548597:Transitional [Idea or Concept]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "such as copper,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "which"

Phrase: "implies"

Phrase: "that A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "redox-active transition metals in vivo where trace metal concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "extremely low."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]
Processing 00000000.tx.302: Any biological significance of the catalytic role of the toxic A peptides in the transition metal-mediated oxidation of hydroxylamine is yet to be determined. 

Phrase: "Any biological significance of the catalytic role of the toxic A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0237881:Significance [Quantitative Concept]
   736   C0750502:Significance [Idea or Concept]

Phrase: "in the transition metal-mediated oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:Oxidation [Molecular Function]

Phrase: "of hydroxylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020362:Hydroxylamine [Inorganic Chemical]

Phrase: "is"

Phrase: "yet to"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.303: Although these hydroxylamines do not occur naturally, other easily oxidized substances exist in vivo such as ascorbate and GSH. 

Phrase: "Although"

Phrase: "these hydroxylamines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020363:Hydroxylamines [Organic Chemical]
   966 E C0020362:Hydroxylamine [Inorganic Chemical]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "naturally,"

Phrase: "other easily oxidized substances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "in vivo such as ascorbate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "GSH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]
Processing 00000000.tx.304: Moreover, it is known that copper and iron ions catalyze protein damage and may be partly responsible for the alterations of protein damage in vivo (35). 

Phrase: "Moreover,"

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "iron ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "protein damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010957:Damage [Injury or Poisoning]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "partly responsible for the alterations of protein damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.305: Metal-catalyzed protein damage is associated with oxidative modification of amino acids, for example, formation of protein carbonyl groups (35). 

Phrase: "Metal-catalyzed protein damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010957:Damage [Injury or Poisoning]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "associated with oxidative modification of amino acids,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0001128:Acids [Chemical]
   748   C0311404:Oxidative [Functional Concept]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "formation of protein carbonyl groups"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1563721:Protein Carbonyl Formation [Molecular Function]
   797   C0597295:protein formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.306: Therefore, the previously reported inactivation of glutamine synthetase and creatine kinase incubated with A-(25-35) (14) could be explained on the basis of metal-catalyzed protein damage. 

Phrase: "Therefore,"

Phrase: "the previously reported inactivation of glutamine synthetase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "creatine kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010287:Creatine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "incubated with A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(25-35"

Phrase: ")"

Phrase: "(14"

Phrase: ")"

Phrase: "could"

Phrase: "be"

Phrase: "explained on the basis of metal-catalyzed protein damage."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0010957:Damage [Injury or Poisoning]
   742   C0025552:Metal [Inorganic Chemical]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]
   742   C1883709:Damage [Functional Concept]
Processing 00000000.tx.307: Previously, it was shown that iron facilitates A toxicity to cultured cells (36). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "facilitates"

Phrase: "A toxicity to cultured cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.308: Moreover, it was found that iron metabolism is altered in Alzheimer's disease (37), which, in combination with accumulation of A peptides, could result in peroxidative stress in the brains of Alzheimer's disease patients. 

Phrase: "Moreover,"

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that iron metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596803:iron metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "altered in Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0392747:Altered [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "which,"

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with accumulation"

Phrase: "of A peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "result in peroxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0038435:Stress [Finding]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Alzheimer's disease patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.309: It was suggested that lowering the level of available iron could provide a therapeutic approach to Alzheimer's disease (38). 

Phrase: "It"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the level of available iron"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0337439:Iron level [Laboratory Procedure]
   797   C0428578:iron level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a therapeutic approach to Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449445:Approach [Spatial Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.310: Furthermore, it was shown that A-(25-35) enhances iron- and copper-catalyzed generation of reactive oxygen species (39). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "iron-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "copper-catalyzed generation of reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.311: Therefore, our data concerning toxic A-stimulated metal-catalyzed oxidation of hydroxylamine derivatives could give insight into the synergetic toxicity of transition metals and A peptides. 

Phrase: "Therefore,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "toxic A-stimulated metal-catalyzed oxidation of hydroxylamine derivatives"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0025552:Metal [Inorganic Chemical]
   742   C0030011:Oxidation [Molecular Function]

Phrase: "could"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "insight into the synergetic toxicity of transition metals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]

Phrase: "and"

Phrase: "A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.312: The data obtained lead to the conclusion that A peptides do not form ESR-detectable radical adducts spontaneously. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "lead to the conclusion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "ESR-detectable radical adducts spontaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596040:adducts [Chemical Viewed Structurally]
Processing 00000000.tx.313: Our spin-trapping results and interpretation differ from the previous investigations (14-17). 

Phrase: "Our spin-trapping results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C0282665:Spin Trapping [Laboratory Procedure]

Phrase: "and"

Phrase: "interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "differ from the previous investigations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205156:Previous [Temporal Concept]
   760   C1261322:Investigations [Health Care Activity]
   760   C1552607:previous [Temporal Concept]
   726 E C1552578:investigation [Idea or Concept]

Phrase: "(14-17"

Phrase: ")."
Processing 00000000.tx.314: Our data do not support the conclusion that A peptides spontaneously form free radicals, but demonstrate that hydroxylamine impurities in the spin trap preparations are responsible for the observed ESR spectra. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that A peptides spontaneously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "but"

Phrase: "demonstrate"

Phrase: "that hydroxylamine impurities in the spin trap preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2698670:IMPURITIES [Regulation or Law]

Phrase: "are"

Phrase: "responsible for the observed ESR spectra."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]
Processing 00000000.tx.315: Therefore, the reported spontaneous generation of PBN radical adducts by A peptides has been reinterpreted. 

Phrase: "Therefore,"

Phrase: "the reported spontaneous generation of PBN radical adducts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C2348402:Spontaneous Report [Intellectual Product]
   744   C0079411:Generation [Temporal Concept]
   744   C0205359:Spontaneous [Functional Concept]
   744   C3146294:Generation [Activity]

Phrase: "by A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reinterpreted."
Processing 00000000.tx.316: Although the spontaneous free radical model of A neurotoxicity has been criticized by Sayre et al. 

Phrase: "Although"

Phrase: "the spontaneous free radical model of A neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "criticized by Sayre et al."
Processing 00000000.tx.317: (40), the previous spin-trapping results and interpretations have not been challenged until now.  

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the previous spin-trapping results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "and"

Phrase: "interpretations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0459471:interpretations [Intellectual Product]
   966 E C3173575:Interpretation [Clinical Attribute]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "challenged until now."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1948052:Now [Temporal Concept]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.318: FOOTNOTES * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.319: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.320: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.321: To whom correspondence should be addressed: Laboratory of Pharmacology and Chemistry, NIEHS/National Institutes of Health, 111Alexander Dr., P.O. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Laboratory of Pharmacology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022877:Laboratory [Manufactured Object,Organization]
   790   C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "Chemistry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007996:Chemistry [Occupation or Discipline]
  1000   C0079107:chemistry [Classification]
  1000   C0201682:Chemistry [Laboratory Procedure]

Phrase: "NIEHS/National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   937   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   804   C0018684:Health [Idea or Concept]
   804   C0021622:Institutes [Organization]
   804   C3245503:national [Intellectual Product]
   771 E C1272753:Institute [Idea or Concept]
   704 E C0031206:healthiness [Finding]

Phrase: "111Alexander Dr., P.O."
Processing 00000000.tx.322: Box 12233,Research Triangle Park, NC 27709.Tel.: 

Phrase: "Box 12233,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Research Triangle Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "NC 27709.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.323: 919-541-2687; 

Phrase: "919-541-2687"

Phrase: ";"
Processing 00000000.tx.324: Fax: 919-541-1043; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "919-541-1043"

Phrase: ";"
Processing 00000000.tx.325: E-mail: dikalov{at}niehs.nih.gov . Permanent address: Institute of Chemical Kinetics and Combustion, Novosibirsk 630090,Russia. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dikalov{at}niehs.nih.gov . Permanent address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0376649:Address [Intellectual Product]
   795   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Institute of Chemical Kinetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Combustion,"

Phrase: "Novosibirsk 630090,"

Phrase: "Russia."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0035970:Russia [Geographic Area]
   928 E C0035967:RUSSIAN [Language]
   928 E C0337816:Russian [Population Group]
Processing 00000000.tx.326: 2 This program is available to the public via the World Wide Web (http://epr.niehs.nih.gov/).  

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "This program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "is"

Phrase: "available to the public"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "via the World Wide Web"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0282111:World Wide Web [Manufactured Object]
           Web
   827   C0332464:Wide [Spatial Concept]
   827   C2700280:World [Population Group]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//epr.niehs.nih.gov/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1419208:GOV [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.327: ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.328: A, amyloid ; ESR, electron spin resonance; 

Phrase: "A,"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; ESR,"

Phrase: "electron spin resonance"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0013845:Electron Spin Resonance [Laboratory Procedure]
   827   C0013852:Electron [Quantitative Concept]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   827   C1415347:SPIN [Gene or Genome]
   827   C1823107:SPIN [Gene or Genome]
   827   C3463986:Electron [Bird]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.329: OMRF, Oklahoma Medical Research Foundation; 

Phrase: "OMRF,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "Oklahoma Medical Research Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.330: PBN, N-tert-butyl--phenylnitrone; 

Phrase: "PBN,"

Phrase: "N-tert-butyl"

Phrase: "--"

Phrase: "phenylnitrone"

Phrase: ";"
Processing 00000000.tx.331: APP, amyloid peptide precursor; 

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "amyloid peptide precursor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.332: PSEN, presenilin; 

Phrase: "PSEN,"

Phrase: "presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.333: APOE, apolipoprotein E; 

Phrase: "APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.334: HPLC, high pressure liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high pressure liquid chromatography"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.335: TEMPONE-H, cyclic hydroxylamine 1-hydroxy-4-oxo-2,2,6,6-tetramethylpiperidine.  

Phrase: "TEMPONE-H,"

Phrase: "cyclic hydroxylamine 1-hydroxy-4-oxo-2,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   795   C0020362:Hydroxylamine [Inorganic Chemical]
   795   C0393003:OXO [Organic Chemical,Pharmacologic Substance]
   795   C0439596:Cyclic [Temporal Concept]
   795   C0700307:Hydroxy [Inorganic Chemical]
   795   C1511572:Cyclic [Temporal Concept]
   724 E C0031084:Cyclicities [Temporal Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "6-tetramethylpiperidine."
Processing 00000000.tx.336: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Saunders, A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.337: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.338: J., Schmechel, D., St. 

Phrase: "J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.339: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.340: H., Pericak-Vance, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: A., Joo, S. 

Phrase: "A.,"

Phrase: "Joo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.342: H., Rosi, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rosi,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.343: L., Gusella, J. 

Phrase: "L., Gusella,"

Phrase: "J."
Processing 00000000.tx.344: F., Crapper-MacLachlan, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crapper-MacLachlan,"

Phrase: "D."
Processing 00000000.tx.345: R., Alberts, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alberts,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A. 

Phrase: "J.,"

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crain,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.347: D. 

Phrase: "D."
Processing 00000000.tx.348: (1993) Neurology 43, 1467-1472[Abstract] Xia, W., Zhang, J., Perez, R., Koo, E. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neurology 43,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1467-1472"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Perez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.349: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.350: J. 

Phrase: "J."
Processing 00000000.tx.351: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.352: Natl. 

Phrase: "Natl."
Processing 00000000.tx.353: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.354: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.355: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.356: 94, 8208-8213[Abstract/Free FullText] Younkin, S. 

Phrase: "94,"

Phrase: "8208-8213"

Phrase: "[Abstract/Free FullText"

Phrase: "] Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.357: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.358: (1995) Ann. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.359: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.360: 37, 287-288[Medline] [OrderarticleviaInfotrieve] Schmechel, D. 

Phrase: "37,"

Phrase: "287-288"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schmechel,"

Phrase: "D."
Processing 00000000.tx.361: E., Saunders, A. 

Phrase: "E.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.362: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.363: J., Crain, B. 

Phrase: "J.,"

Phrase: "Crain,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.364: J., Hulette, C. 

Phrase: "J.,"

Phrase: "Hulette,"

Phrase: "C."
Processing 00000000.tx.365: M., Joo, S. 

Phrase: "M."

Phrase: ","

Phrase: "Joo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.366: H., Pericak-Vance, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.367: A., Goldgaber, D., and Roses, A. 

Phrase: "A.,"

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.368: D. 

Phrase: "D."
Processing 00000000.tx.369: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.370: Natl. 

Phrase: "Natl."
Processing 00000000.tx.371: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.372: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.373: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.374: 90, 9649-9653[Abstract] Yankner, B. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "9649-9653"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.375: A., Duffy, L. 

Phrase: "A.,"

Phrase: "Duffy,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.376: K., and Kirschner, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "D."
Processing 00000000.tx.377: A. 

Phrase: "A."
Processing 00000000.tx.378: (1990) Science 250, 279-282[Medline] [OrderarticleviaInfotrieve] Smith, M. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 250,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "279-282"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: A., Harris, P. 

Phrase: "A.,"

Phrase: "Harris,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.380: L.R., Sayre, L. 

Phrase: "L.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sayre,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.381: M., Beckman, J. 

Phrase: "M."

Phrase: ","

Phrase: "Beckman,"

Phrase: "J."
Processing 00000000.tx.382: S., and Perry, G. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.383: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.384: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.385: 17, 2653-2657[Abstract/Free FullText] Subbarao, K. 

Phrase: "17,"

Phrase: "2653-2657"

Phrase: "[Abstract/Free FullText"

Phrase: "] Subbarao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.386: V., Richardson, J. 

Phrase: "V., Richardson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443048:Richardson [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.387: S., and Ang, L. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.388: C. 

Phrase: "C."
Processing 00000000.tx.389: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.391: 55, 342-345[Medline] [OrderarticleviaInfotrieve] Montine, K. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "342-345"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Montine,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.392: S., Reich, E., Neely, M. 

Phrase: "S."

Phrase: ","

Phrase: "Reich,"

Phrase: "E.,"

Phrase: "Neely,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.393: D., Sidell, K. 

Phrase: "D."

Phrase: ","

Phrase: "Sidell,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.394: R., Olson, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Olson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.395: J., Markesbery, W. 

Phrase: "J.,"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.396: R., and Montine, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Montine,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.397: J. 

Phrase: "J."
Processing 00000000.tx.398: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.399: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.400: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.401: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.402: 57, 415-425[Medline] [OrderarticleviaInfotrieve] Mecocci, P., MacGarvey, U., and Beal, M. 

Phrase: "57,"

Phrase: "415-425"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mecocci,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "MacGarvey,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.404: (1994) Ann. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.405: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.406: 36, 747-751[Medline] [OrderarticleviaInfotrieve] Behl, C., Davis, J. 

Phrase: "36,"

Phrase: "747-751"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Behl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Davis,"

Phrase: "J."
Processing 00000000.tx.407: B., Lesley, R., and Schubert, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lesley,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schubert,"

Phrase: "D."
Processing 00000000.tx.408: (1994) Cell 77, 817-827[Medline] [OrderarticleviaInfotrieve] Klegeris, A., and McGeer, P. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 77,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "817-827"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Klegeris,"

Phrase: "A.,"

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.409: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.410: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.411: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.412: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.413: 49, 229-235[CrossRef][Medline] [OrderarticleviaInfotrieve] Akama, K. 

Phrase: "49,"

Phrase: "229-235"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Akama,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.414: T., Albanese, C., Pestell, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Albanese,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pestell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.415: G., and Van Eldik, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Van Eldik,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.416: J. 

Phrase: "J."
Processing 00000000.tx.417: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.418: Natl. 

Phrase: "Natl."
Processing 00000000.tx.419: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.420: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.421: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.422: 95, 5795-5800[Abstract/Free FullText] Kato, M., Saito, H., and Abe, K. 

Phrase: "95,"

Phrase: "5795-5800"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "M."

Phrase: ","

Phrase: "Saito,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Abe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155685:abe [Disease or Syndrome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.423: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.424: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.425: 68, 1889-1895[Medline] [OrderarticleviaInfotrieve] Hensley, K., Carney, J. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "1889-1895"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Carney,"

Phrase: "J."
Processing 00000000.tx.426: M., Mattson, M. 

Phrase: "M."

Phrase: ","

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.427: P., Aksenova, M., Harris, M., Wu, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Aksenova,"

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "M."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.428: F., Floyd, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Floyd,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.429: A., and Butterfield, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.430: A. 

Phrase: "A."
Processing 00000000.tx.431: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.432: Natl. 

Phrase: "Natl."
Processing 00000000.tx.433: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.434: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.435: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.436: 91, 3270-3274[Abstract] Butterfield, D. 

Phrase: "91,"

Phrase: "3270-3274"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Butterfield,"

Phrase: "D."
Processing 00000000.tx.437: A. 

Phrase: "A."
Processing 00000000.tx.438: (1997) Chem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.439: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.440: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.441: 10, 495-506[CrossRef][Medline] [OrderarticleviaInfotrieve] Hensley, K., Aksenova, M., Carney, J. 

Phrase: "10,"

Phrase: "495-506"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Aksenova,"

Phrase: "M."

Phrase: ","

Phrase: "Carney,"

Phrase: "J."
Processing 00000000.tx.442: M., Harris, M., and Butterfield, D. 

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.443: A. 

Phrase: "A."
Processing 00000000.tx.444: (1995) Neuroreport 6, 489-492[Medline] [OrderarticleviaInfotrieve] Hensley, K., Aksenova, M., Carney, J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuroreport 6,"

Phrase: "489-492"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Aksenova,"

Phrase: "M."

Phrase: ","

Phrase: "Carney,"

Phrase: "J."
Processing 00000000.tx.445: M., Harris, M., and Butterfield, D. 

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.446: A. 

Phrase: "A."
Processing 00000000.tx.447: (1995) Neuroreport 6, 493-496[Medline] [OrderarticleviaInfotrieve] Davies, Michael, J., and Dean, R. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuroreport 6,"

Phrase: "493-496"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Davies,"

Phrase: "Michael,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Dean,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.448: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.449: (1997) Radical-mediated Protein Oxidation: From Chemistry to Medicine, pp. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Radical-mediated Protein Oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1159301:protein oxidation [Molecular Function]
   812   C0030011:Oxidation [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "From Chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007996:Chemistry [Occupation or Discipline]
  1000   C0079107:chemistry [Classification]
  1000   C0201682:Chemistry [Laboratory Procedure]

Phrase: "to Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "pp."
Processing 00000000.tx.450: 235-237, Oxford University Press, Oxford Lovell, M. 

Phrase: "235-237,"

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.451: A., Robertson, J. 

Phrase: "A.,"

Phrase: "Robertson,"

Phrase: "J."
Processing 00000000.tx.452: D., Teesdale, W. 

Phrase: "D."

Phrase: ","

Phrase: "Teesdale,"

Phrase: "W."
Processing 00000000.tx.453: J., Campbell, J. 

Phrase: "J.,"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.454: L., and Markesbery, W. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.455: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.456: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.457: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.458: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.459: 158, 47-52[CrossRef][Medline] [OrderarticleviaInfotrieve] Balakrishnan, R., Parthasarathy, R., and Sulkowski, E. 

Phrase: "158,"

Phrase: "47-52"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Balakrishnan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Parthasarathy,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sulkowski,"

Phrase: "E."
Processing 00000000.tx.460: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.461: Pept. 

Phrase: "Pept."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.462: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.463: 51, 91-95[Medline] [OrderarticleviaInfotrieve] Atwood, C. 

Phrase: "51,"

Phrase: "91-95"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Atwood,"

Phrase: "C."
Processing 00000000.tx.464: S., Moir, R. 

Phrase: "S."

Phrase: ","

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: D., Huang, X., Scarpa, R. 

Phrase: "D."

Phrase: ","

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.466: C., Bacarra, N. 

Phrase: "C., Bacarra,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.467: M.E., Romano, D. 

Phrase: "M."

Phrase: "E.,"

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.468: M., Hartshorn, M. 

Phrase: "M."

Phrase: ","

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.470: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.471: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.472: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.473: Biol. 

Phrase: "Biol."
Processing 00000000.tx.474: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.475: 273, 12817-12826[Abstract/Free FullText] Dikalov, S., Skatchkov, M., and Bassenge, E. 

Phrase: "273,"

Phrase: "12817-12826"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dikalov,"

Phrase: "S."

Phrase: ","

Phrase: "Skatchkov,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bassenge,"

Phrase: "E."
Processing 00000000.tx.476: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.477: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.478: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.479: Commun. 

Phrase: "Commun."
Processing 00000000.tx.480: 230, 54-57[CrossRef][Medline] [OrderarticleviaInfotrieve] Duling, D. 

Phrase: "230,"

Phrase: "54-57"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Duling,"

Phrase: "D."
Processing 00000000.tx.481: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.482: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.483: Magn. 

Phrase: "Magn."
Processing 00000000.tx.484: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.485: Ser. 

Phrase: "Ser."
Processing 00000000.tx.486: B 104, 105-110[CrossRef][Medline] [OrderarticleviaInfotrieve] Kalyanaraman, B., Perez-Reyes, E., and Mason, R. 

Phrase: "B 104,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "105-110"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kalyanaraman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Perez-Reyes,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.487: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.488: (1979) Tetrahedron Lett. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Tetrahedron Lett."
Processing 00000000.tx.489: 50, 4809-4812 Lagercrantz, C. 

Phrase: "50,"

Phrase: "4809-4812 Lagercrantz,"

Phrase: "C."
Processing 00000000.tx.490: (1991) Free Radical Res. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Free Radical Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
Processing 00000000.tx.491: Commun. 

Phrase: "Commun."
Processing 00000000.tx.492: 14, 395-407[Medline] [OrderarticleviaInfotrieve] Wertz, J. 

Phrase: "14,"

Phrase: "395-407"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wertz,"

Phrase: "J."
Processing 00000000.tx.493: E., and Bolton, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bolton,"

Phrase: "J."
Processing 00000000.tx.494: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.495: (1986) Electron Spin Resonance: Elementary Theory and Practical Applications, pp. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Electron Spin Resonance"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0013845:Electron Spin Resonance [Laboratory Procedure]
   827   C0013852:Electron [Quantitative Concept]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   827   C1415347:SPIN [Gene or Genome]
   827   C1823107:SPIN [Gene or Genome]
   827   C3463986:Electron [Bird]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: ":"

Phrase: "Elementary Theory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871935:Theory [Idea or Concept]

Phrase: "and"

Phrase: "Practical Applications,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0185125:applications [Health Care Activity]
   827 E C1947919:Application [Intellectual Product]
   827 E C2347934:Application [Intellectual Product]
   827 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "pp."
Processing 00000000.tx.496: 450-457, Chapman and Hall, New York Cohen, G. 

Phrase: "450-457,"

Phrase: "Chapman"

Phrase: "and"

Phrase: "Hall,"

Phrase: "New York Cohen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.497: (1985) in CRC Handbook of Methods for Oxygen Radical Research (Greenwald, A., ed), pp. 

Phrase: "(1985"

Phrase: ")"

Phrase: "in CRC Handbook"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596654:handbook [Intellectual Product]

Phrase: "of Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "for Oxygen Radical Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]

Phrase: "(Greenwald,"

Phrase: "A.,"

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.498: 55-64, CRC Press, Boca Raton, FL Hanna, P. 

Phrase: "55-64,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "CRC Press,"

Phrase: "Boca Raton,"

Phrase: "FL Hanna,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.499: M., and Mason, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.500: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.501: (1992) Arch. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.502: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.503: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.504: 295, 205-213[CrossRef][Medline] [OrderarticleviaInfotrieve] Mackor, A., Wajer, Th. 

Phrase: "295,"

Phrase: "205-213"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mackor,"

Phrase: "A.,"

Phrase: "Wajer,"

Phrase: "Th."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039725:TH [Geographic Area]
  1000   C0039738:Th [Element, Ion, or Isotope]
  1000   C1420718:TH [Gene or Genome]
Processing 00000000.tx.505: A.J.W., de Boer, Th. 

Phrase: "A.J.W., de Boer,"

Phrase: "Th."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039725:TH [Geographic Area]
  1000   C0039738:Th [Element, Ion, or Isotope]
  1000   C1420718:TH [Gene or Genome]
Processing 00000000.tx.506: J., and van Voorst, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "van Voorst,"

Phrase: "J."
Processing 00000000.tx.507: D.W. 

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.508: (1967) Tetrahedron Lett. 

Phrase: "(1967"

Phrase: ")"

Phrase: "Tetrahedron Lett."
Processing 00000000.tx.509: 5, 385-390 Chamulitrat, W., Takahashi, N., and Mason, R. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "385-390 Chamulitrat,"

Phrase: "W.,"

Phrase: "Takahashi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.510: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.511: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.512: Biol. 

Phrase: "Biol."
Processing 00000000.tx.513: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.514: 264, 7889-7899[Abstract/Free FullText] Hinton, R. 

Phrase: "264,"

Phrase: "7889-7899"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hinton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: D., and Janzen, E. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Janzen,"

Phrase: "E."
Processing 00000000.tx.516: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.517: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.518: Org. 

Phrase: "Org."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522486:ORG [Professional or Occupational Group]
Processing 00000000.tx.519: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.520: 57, 2646-2651 Makino, K., Suzuki, N., Moriya, F., Rokushika, S., and Hatano, H. 

Phrase: "57,"

Phrase: "2646-2651 Makino,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Moriya,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rokushika,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hatano,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.521: (1981) Radical Res. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Radical Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.522: 86, 294-310 Chamulitrat, W., Jordan, S. 

Phrase: "86,"

Phrase: "294-310 Chamulitrat,"

Phrase: "W.,"

Phrase: "Jordan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:Jordan [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.523: J., Mason, R. 

Phrase: "J.,"

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.524: P., Saito, K., and Cutler, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saito,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Cutler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.525: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.526: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.527: Biol. 

Phrase: "Biol."
Processing 00000000.tx.528: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.529: 268, 11520-11527[Abstract/Free FullText] Sentjurc, M., and Mason, R. 

Phrase: "268,"

Phrase: "11520-11527"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sentjurc,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.530: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.531: (1992) Free Radical Biol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Free Radical Biol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
Processing 00000000.tx.532: Med. 

Phrase: "Med."
Processing 00000000.tx.533: 13, 151-160[Medline] [OrderarticleviaInfotrieve] Stadtman, E. 

Phrase: "13,"

Phrase: "151-160"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stadtman,"

Phrase: "E."
Processing 00000000.tx.534: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.535: (1990) Free Radical Biol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Free Radical Biol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
Processing 00000000.tx.536: Med. 

Phrase: "Med."
Processing 00000000.tx.537: 9, 315-325[CrossRef][Medline] [OrderarticleviaInfotrieve] Schubert, D., and Chevion, M. 

Phrase: "9,"

Phrase: "315-325"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schubert,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Chevion,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: (1995) Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.539: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.540: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.541: Commun. 

Phrase: "Commun."
Processing 00000000.tx.542: 216, 702-707[CrossRef][Medline] [OrderarticleviaInfotrieve] Smith, M. 

Phrase: "216,"

Phrase: "702-707"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: A., and Perry, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.545: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.546: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.547: 134S, 92-94[CrossRef][Medline] [OrderarticleviaInfotrieve] Benzi, G., and Morretti, A. 

Phrase: "134S,"

Phrase: "92-94"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Benzi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Morretti,"

Phrase: "A."
Processing 00000000.tx.548: (1995) Neurobiol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.549: Aging 16, 661-674[CrossRef][Medline] [OrderarticleviaInfotrieve] Bondy, S. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "16,"

Phrase: "661-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bondy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.550: C., Guo-Ross, S. 

Phrase: "C., Guo-Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0331968:Ross [Health Care Related Organization]
   827   C2699100:Ross [Bird]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.551: X., and Truong, A. 

Phrase: "X.,"

Phrase: "and"

Phrase: "Truong,"

Phrase: "A."
Processing 00000000.tx.552: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.553: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.554: 799, 91-96[CrossRef][Medline] [OrderarticleviaInfotrieve] Sayre, L. 

Phrase: "799,"

Phrase: "91-96"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sayre,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.555: M., Zagorski, M. 

Phrase: "M."

Phrase: ","

Phrase: "Zagorski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.556: G., Surewicz, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Surewicz,"

Phrase: "W."
Processing 00000000.tx.557: K., Krafft, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.558: A., and Perry, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.559: (1997) Chem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.560: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.561: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.562: 10, 518-526[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "10,"

Phrase: "518-526"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  1999 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

